Venous thromboembolism

I9_VTE

Phlebitis: Inflammation of a vein.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I26, I80, O87.1, O88.2 Hospital discharge: ICD-9 — 415\|451\|6713\|6714\|6732 Hospital discharge: ICD-8 — 450\|451\|671\|6739 Hospital discharge: excluded ICD-10 — I80.0# Hospital discharge: excluded ICD-9 — 4510 Cause of death: ICD-10 — I26, I80, O87.1, O88.2 Cause of death: ICD-9 — 415\|451\|6713\|6714\|6732 Cause of death: ICD-8 — 450\|451\|671\|6739 Cause of death: excluded ICD-10 — I80.0# Cause of death: excluded ICD-9 — 4510 2 out of 7 registries used, show all original rules.	32340
4. Check minimum number of events None	32340
5. Include endpoints None	32340
6. Filter based on genotype QC (FinnGen only)	28926

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF2

NAME	I9_VTE
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I26\|I80\|O871\|O882
HD_ICD_9	415\|451\|6713\|6714\|6732
HD_ICD_8	450\|451\|671\|6739
HD_ICD_10_EXCL	I800
HD_ICD_9_EXCL	4510
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I26\|I80\|O871\|O882
COD_ICD_9	415\|451\|6713\|6714\|6732
COD_ICD_8	450\|451\|671\|6739
COD_ICD_10_EXCL	I800
COD_ICD_9_EXCL	4510
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Venous thromboembolism based on the number of shared cases.

Similar with more cases:

None

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	248674	138776	106624
Only index persons	178972	102819	76153
Unadjusted period prevalence (%)
Whole population	3.54	3.97	2.98
Only index persons	3.41	3.78	2.91
Median age at first event (years)
Whole population	65.14	66.44	63.36
Only index persons	62.36	63.33	61.06

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	28926	15643	13283
Unadjusted period prevalence (%)	5.80	5.55	6.09
Median age at first event (years)	61.33	59.33	63.68

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
29778: Matched controls
286619

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

319.7

4379

23281

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

309.9

5068

28522

B01AB05

ATC

enoxaparin; parenteral

4.2

307.7

15777

61088

B01AB10

ATC

tinzaparin; parenteral

3.4

307.7

5238

17013

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

12.9

307.7

1640

1288

K94

ICPC

Phlebitis/thrombophlebitis

15.2

307.7

1421

941

GD2SN

NOMESCO Finland

Lung ventilation SPECT

10.8

307.7

464

420

C03CA01

ATC

furosemide; systemic

2.0

307.7

11781

70111

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

307.7

6651

37987

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

307.7

4316

20267

B01AA03

ATC

warfarin; systemic

5.5

307.7

12890

34687

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

1000.0

307.7

3885

45100

ICD-8 Finland

Phlebitis and thrombophlebitis, Of lower extremities

+∞

307.7

1142

4151A

ICD-9 Finland

Acute pulmonary heart disease, Pulmonary embolism and infarction

+∞

307.7

464

J01MA12

ATC

levofloxacin; systemic

1.8

307.7

6007

35180

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

7.0

307.7

5812

9555

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

6.2

307.7

1660

2706

N02AA05

ATC

oxycodone; systemic

2.2

307.7

7129

36236

M79.6

ICD-10 Finland

Pain in limb

1.8

307.7

13664

92019

B01AF01

ATC

rivaroxaban; oral

3.1

307.7

6063

21976

R60.0

ICD-10 Finland

Localized oedema

2.3

307.7

5016

22806

I87.0

ICD-10 Finland

Postthrombotic syndrome

41.3

307.7

323

130

Kela drug reimbursment

Malignant tumour

2.3

307.7

3212

14592

R06.0

ICD-10 Finland

Dyspnoea

2.3

307.7

10552

54515

B01AF02

ATC

apixaban; oral

3.5

307.7

7308

24407

JN4AD

NOMESCO Finland

Body CT examination

2.1

307.7

4175

20494

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

155.1

307.7

2442

165

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

5.6

307.7

964

1688

A46

ICD-10 Finland

Erysipelas

2.0

307.7

5328

27648

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

13.7

307.7

1620

1202

JN4BD

NOMESCO Finland

Extensive body CT

2.2

307.7

3644

16908

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

307.7

7353

41365

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.5

307.7

5221

22787

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3.1

307.7

1713

5577

N02AX02

ATC

tramadol; systemic, rectal

1.7

307.7

13547

94022

A02BC02

ATC

pantoprazole; systemic

1.7

307.7

20510

163602

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

307.7

16458

107654

GD1UN

NOMESCO Finland

Lung circulation SPECT

11.5

307.7

378

321

H02AB02

ATC

dexamethasone; systemic

2.3

307.7

4096

18483

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

307.7

3860

18987

I26

ICD-10 Finland

Pulmonary embolism

76.5

307.7

1329

175

D68.8

ICD-10 Finland

Other specified coagulation defects

15.9

307.7

912

569

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

6.8

307.7

2635

4055

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

7.0

307.7

9109

16954

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

66.1

307.7

2095

328

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

94.8

307.7

2526

280

I80.20

ICD-10 Finland

Phlebitis and thrombophlebitis in the iliac vein

440.1

307.7

714

R50.9

ICD-10 Finland

Fever, unspecified

1.9

307.7

4811

26256

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

72.4

307.7

6654

1134

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

117.7

307.7

4901

479

4511A

ICD-9 Finland

Phlebitis and thrombophlebitis, Of deep vessels of lower extremities

+∞

307.7

1366

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

89.7

307.7

5930

792

Z51.5

ICD-10 Finland

Palliative care

2.2

307.7

3318

15372

K93

ICPC

Pulmonary embolism

89.4

307.7

1475

167

B01AB04

ATC

dalteparin; parenteral

4.4

307.7

2823

6616

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1066.2

307.7

12487

194

H02AB06

ATC

prednisolone; systemic

1.6

307.7

14561

105226

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.3

307.7

4195

19306

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

28.3

307.7

997

350

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.0

307.7

5999

32056

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

307.7

9514

55529

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

307.7

7147

42514

I80

ICD-10 Finland

Phlebitis and thrombophlebitis

9.2

307.7

829

891

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.3

298.5

1157

3424

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

295.3

5968

35731

A04AA01

ATC

ondansetron; systemic, rectal

2.2

291.5

2748

12704

R4110

NOMESCO Finland

Physiotherapy

1.6

273.0

8265

54888

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.8

268.8

1444

5150

N03AX16

ATC

[U] pregabalin

1.7

267.6

6850

43575

AA1AD

NOMESCO Finland

CT of head and brain

1.6

258.0

9040

61989

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

257.7

8871

60574

I80.2

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

+∞

257.0

250

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.3

256.9

2072

8962

A04AA02

ATC

granisetron; systemic, transdermal

2.3

255.6

2066

8943

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

252.2

10349

73447

ZX120

NOMESCO Finland

Intravenous

2.0

246.8

2923

14686

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

245.2

4690

27473

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

241.7

11950

88037

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

241.3

3090

15948

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.5

241.2

1661

6690

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

236.0

7122

46962

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

232.3

4335

25178

ZXD05

NOMESCO Finland

Urgent procedure

1.5

226.4

8423

58176

N02BE01

ATC

paracetamol; systemic, rectal

1.8

224.2

25998

227999

R60.9

ICD-10 Finland

Oedema, unspecified

2.2

220.0

1973

8903

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

219.6

3566

19845

J01FF01

ATC

clindamycin; systemic

1.6

217.4

7610

51762

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

216.4

12276

92333

PH2AE, ,

SPAT

3.5

216.1

768

2147

L28

ICPC

Limited function/disability (L)

1.6

216.0

6032

38912

J01DB01

ATC

cefalexin; oral

1.6

213.7

23432

200747

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

213.5

5504

34798

A28

ICPC

Limited function/disability NOS

1.6

212.8

5817

37312

Z3226

NOMESCO Finland

Physiotherapist

1.7

212.4

5144

32003

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

212.2

9510

68143

R02

ICPC

Shortness of breath/dyspnoea

1.7

210.8

4221

24952

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

207.8

4881

30108

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

3.1

204.1

879

2767

L14

ICPC

Leg/thigh symptom/complaint

2.0

203.2

2582

13253

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

202.8

10026

73113

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

202.4

7133

48456

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

2.6

201.6

1236

4703

WF049

NOMESCO Finland

Radiotherapy of metastasis

2.6

199.6

1246

4783

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

199.1

9923

72413

J01MA02

ATC

ciprofloxacin; systemic

1.5

198.7

11364

85163

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

198.2

4766

29542

45001

ICD-8 Finland

Pulmonary embolism and infarction, Embolia

+∞

197.3

192

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.3

194.2

1549

6647

A08

ICPC

Swelling

2.1

193.7

1940

9129

D68.2

ICD-10 Finland

Hereditary deficiency of other clotting factors

15.3

191.7

171

108

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

191.2

8286

58683

WX892

NOMESCO Finland

Monitored bed care

2.0

188.6

2345

11933

R03AC02

ATC

salbutamol; inhalant

1.4

187.0

14841

117681

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

187.0

4862

30687

K99

ICPC

Cardiovascular disease other

2.8

186.4

993

3517

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

186.3

2038

9908

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

185.4

4004

24091

Z3231

NOMESCO Finland

Registered nurse

1.5

184.1

7621

53388

I82

ICD-10 Finland

Other venous embolism and thrombosis

11.5

183.3

193

162

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

183.2

10051

74409

L17

ICPC

Foot/toe symptom/complaint

1.5

182.7

8654

62272

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

181.2

4799

30401

S97

ICPC

Chronic ulcer skin

2.0

179.1

2098

10450

L01BC06

ATC

capecitabine; oral

2.4

177.9

1263

5146

SPAT1254

SPAT

Administration of medicine

1.6

176.1

4298

26662

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

175.7

5233

34064

A06AD11

ATC

lactulose; oral

1.6

173.1

4602

29147

O22.3

ICD-10 Finland

Deep phlebothrombosis in pregnancy

28.0

172.0

119

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

170.9

2721

14983

M04AA01

ATC

allopurinol; systemic

1.7

170.0

4046

24921

J01MA14

ATC

moxifloxacin; systemic

1.8

165.9

2602

14257

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

164.5

3078

17763

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

163.9

2370

12656

E66.01

ICD-10 Finland

Obesity due to excess calories

1.9

163.7

2386

12774

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

3.0

163.3

761

2505

D68.9

ICD-10 Finland

Coagulation defect, unspecified

9.3

163.2

200

209

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

2.9

162.5

792

2673

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.7

162.4

3156

18402

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

161.3

2768

15574

B01AX05

ATC

fondaparinux; parenteral

4.9

160.5

359

710

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

160.5

5338

35536

UJF32

NOMESCO Finland

Coloscopy

1.5

157.4

7526

53936

R53

ICD-10 Finland

Malaise and fatigue

1.5

156.7

7086

50234

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

6.5

156.3

259

386

L03AA13

ATC

pegfilgrastim; parenteral

2.2

154.3

1312

5774

Z86.7

ICD-10 Finland

Personal history of diseases of the circulatory system

30.8

151.8

102

ZXE00

NOMESCO Finland

One hour or less

1.4

149.1

10252

78252

I82.80

ICD-10 Finland

Emboli and thrombosis in the subclavian vein

14.0

148.4

139

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.7

148.1

2818

16311

Z2446

NOMESCO Finland

Social worker

2.0

147.7

1696

8372

R03BB04

ATC

tiotropium bromide; inhalant

1.7

147.4

3051

18072

WW500

NOMESCO Finland

Blood transfusion

2.3

147.1

1236

5411

WZC30

NOMESCO Finland

Teaching

1.6

146.1

4571

29950

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

145.4

2864

16734

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

4.0

144.6

425

1042

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

2.6

144.5

872

3287

SPAT1229

SPAT

Assessment of need for aid

1.8

143.3

2322

12825

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.6

143.2

476

1272

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

142.9

4693

31065

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.0

142.0

1558

7564

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.6

140.4

849

3204

L04AA06

ATC

mycophenolic acid; systemic

3.1

139.1

615

1964

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

138.1

3650

22975

PHD99

NOMESCO Finland

Resection of other vein

2.0

137.9

1713

8686

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

137.3

3870

24729

H02AB07

ATC

prednisone; oral

1.6

136.3

3792

24155

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

136.1

3649

23040

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

2.6

135.8

796

2957

XX3DW

NOMESCO Finland

Time consuming IT work

1.7

134.7

2969

17856

A41.9

ICD-10 Finland

Sepsis, unspecified

2.2

134.3

1140

5009

PHM76

NOMESCO Finland

Endovenous obliteration of v.saphena magna

2.3

132.1

1071

4617

J01DA01

ATC

[U] cefalexin

1.3

132.0

16649

138858

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

131.5

13484

108979

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.0

131.4

1539

7643

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

131.3

1235

5655

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.0

131.0

1462

7137

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

130.2

6166

43842

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.4

129.8

956

3953

A04AA55

ATC

palonosetron, combinations; systemic

2.3

129.4

990

4163

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

129.2

7875

58554

C03DA01

ATC

spironolactone; oral

1.6

128.6

3688

23633

N05CF01

ATC

zopiclone; oral

1.4

128.5

9046

68880

SPAT1255

SPAT

Intravenous administration of medicine

1.8

127.1

1916

10337

L03AA02

ATC

filgrastim; parenteral

2.4

124.9

888

3614

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.1

124.8

1234

5758

N03AX12

ATC

[U] gabapentin; oral

1.5

124.5

4266

28416

4538X

ICD-9 Finland

Other venous embolism and thrombosis, Of other specified veins

9.5

123.8

149

152

PH7YT

NOMESCO Finland

Dilatation of inferior vena cava or lower extremity vein with stent

67.5

123.8

127

Kela drug reimbursment

Transplant complication

3.3

123.4

486

1449

WX002

NOMESCO Finland

Sedation and analgesia

1.5

121.2

5153

35833

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

120.7

1292

6209

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

8.5

120.6

158

180

R52.9

ICD-10 Finland

Pain, unspecified

1.6

119.5

2812

17164

Z2221

NOMESCO Finland

Medical doctor

1.4

118.9

6989

51509

E66.8

ICD-10 Finland

Other obesity

2.0

118.7

1361

6704

R11

ICD-10 Finland

Nausea and vomiting

1.7

118.3

2346

13696

H02AB04

ATC

methylprednisolone; systemic

1.5

117.6

3853

25393

128

Kela drug reimbursment

Cancers of female genital organs

3.0

117.5

543

1778

J96.1

ICD-10 Finland

Chronic respiratory failure

2.6

116.6

713

2704

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

116.0

5211

36579

A02BC01

ATC

omeprazole; systemic

1.4

115.5

7403

55309

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.8

113.6

1791

9787

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.2

113.5

975

4303

A06AH03

ATC

naloxegol; oral

3.1

113.2

478

1486

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

113.0

2219

12912

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.1

112.7

1117

5214

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

112.6

4226

28627

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.9

112.4

1468

7557

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

111.7

9922

77886

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

111.6

1477

7638

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

2.7

111.5

599

2128

J01FA06

ATC

roxithromycin; oral

1.3

111.4

10321

81510

S18

ICPC

Laceration/cut

1.3

111.2

12877

104974

N05BA04

ATC

oxazepam; oral

1.4

110.8

6900

51244

ZXA05

NOMESCO Finland

Left side

1.4

110.3

6618

48842

ZXA00

NOMESCO Finland

Right side

1.4

110.1

7067

52732

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.0

109.9

1295

6438

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.7

109.8

2004

11425

R4190

NOMESCO Finland

Nutritional therapy

2.2

108.9

999

4526

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

108.5

1974

11243

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.1

106.6

1104

5239

SPAT1263

SPAT

Sampling

1.3

106.5

10767

85944

C07AB07

ATC

bisoprolol; oral

1.3

106.2

13992

115819

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

105.9

1714

9436

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.7

105.8

1996

11480

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

105.8

1763

9788

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.8

105.8

559

1969

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.5

105.4

4067

27669

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.1

105.0

1054

4943

PH2BC

NOMESCO Finland

Extensive flebography of lower extremity with X-ray

41.8

104.8

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

103.7

1929

11050

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

8.2

103.2

139

164

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.3

102.4

798

3380

PH7FT

NOMESCO Finland

Inmplantation of filter to inferior vena cava with radiological guidance

120.2

102.4

112

M10.9

ICD-10 Finland

Gout, unspecified

1.7

101.7

2015

11741

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

3.0

101.7

475

1565

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.0

101.7

1240

6235

A02BC05

ATC

esomeprazole; systemic

1.3

100.7

10756

86316

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

6.6

99.6

162

237

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.7

99.0

1755

9916

WX402

NOMESCO Finland

General anaesthesia

1.4

98.6

5582

40678

67100

ICD-8 Finland

Puerperal phlebitis and thrombosis, Thrombophlebitis extremitatis inferioris

+∞

98.6

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

98.6

4884

34781

N30.0

ICD-10 Finland

Acute cystitis

1.4

98.1

4494

31553

JN4CD

NOMESCO Finland

Very extensive body CT

2.1

98.0

1017

4828

GD1CQ

NOMESCO Finland

Lung circulation SPECT with low dose CT

9.9

98.0

114

111

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

97.8

2273

13801

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

97.1

1810

10369

R51.80

ICD-10 Finland

Headache

1.5

96.9

3649

24673

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

96.7

4733

33618

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

96.4

1848

10669

N06AX11

ATC

mirtazapine; oral

1.3

95.4

8847

69479

I50.0

ICD-10 Finland

Congestive heart failure

1.6

94.5

2353

14525

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

93.9

1447

7843

E0000UV, ,

ATC

1.3

93.4

10727

86666

L04AX01

ATC

azathioprine; systemic

2.0

93.3

1056

5173

K07

ICPC

Swollen ankles/oedema

1.8

92.3

1424

7719

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.8

92.1

1462

7994

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

91.8

1121

5636

TK800

NOMESCO Finland

Hemodialysis

2.5

91.4

610

2411

N05BA01

ATC

diazepam; systemic, rectal

1.5

91.0

3310

22203

TGC00

NOMESCO Finland

Bronchial lavation

2.3

90.9

746

3229

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.4

89.3

653

2690

M05BX04

ATC

denosumab; parenteral

1.7

88.7

1748

10159

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

88.7

4487

32007

45309

ICD-8 Finland

Other venous embolism and thrombosis, NUD (cerebri, cordis, mesenterii, pulmonis exceptis)

7.9

87.3

121

148

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

2.6

87.1

524

1971

P01AB01

ATC

metronidazole; oral, rectal

1.3

87.0

10025

80816

WX882

NOMESCO Finland

High dependency care

2.2

86.5

758

3370

45499

ICD-8 Finland

Varicose veins of lower extremities, Other and unspecified, without ulcer

1.7

86.4

1702

9889

A01

ICPC

Pain general/multiple sites

1.5

86.2

2682

17403

J46

ICD-10 Finland

Status asthmaticus

2.2

86.1

780

3514

C02KX04

ATC

macitentan; oral

19.0

85.8

J01AA02

ATC

doxycycline; systemic

1.3

85.4

21337

189169

UKC02

NOMESCO Finland

Cystoscopy

1.4

85.2

4440

31810

J01EA01

ATC

trimethoprim; systemic

1.3

85.2

6651

50798

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.9

84.9

1214

6427

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

2.7

84.7

462

1655

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

84.6

1765

10413

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.5

84.2

2814

18531

R07.3

ICD-10 Finland

Other chest pain

1.5

83.8

2716

17769

WF004

NOMESCO Finland

Palliative radiotherapy

2.3

83.8

634

2651

X58

ICD-10 Finland

Exposure to other specified factors

1.5

83.8

3515

24216

PH7AC

NOMESCO Finland

Lumbal cavography with X-ray

41.8

83.7

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

83.4

2016

12341

PH2AC

NOMESCO Finland

Flebography of lower extremity with X-ray

13.9

83.1

G47.3

ICD-10 Finland

Sleep apnoea

1.4

83.0

5729

42933

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.7

83.0

1475

8330

Z94.0

ICD-10 Finland

Kidney transplant status

3.3

82.9

326

972

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

1.9

82.8

1145

5997

I27.0

ICD-10 Finland

Primary pulmonary hypertension

7.8

82.6

116

144

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

82.6

3142

21239

M54.5

ICD-10 Finland

Low back pain

1.3

81.9

9140

73224

A11CC03

ATC

alfacalcidol; systemic

2.3

81.9

664

2860

N06AB04

ATC

citalopram; systemic

1.4

81.7

5182

38313

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.0

81.5

935

4599

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.8

80.7

1171

6226

R5110, ,

SPAT

1.5

80.2

2382

15287

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.1

80.1

822

3885

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

3.1

80.0

339

1057

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.0

79.9

858

4122

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

79.9

1959

12030

R03BA05

ATC

fluticasone; inhalant

1.4

79.6

4352

31398

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

79.5

3296

22639

H02AB09

ATC

hydrocortisone; systemic

2.3

79.4

594

2472

N06AX16

ATC

venlafaxine; oral

1.5

79.3

3164

21572

C02KX05

ATC

riociguat; oral

761.2

79.3

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.3

78.8

635

2727

E66.9

ICD-10 Finland

Obesity, unspecified

2.0

78.4

841

4039

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

4.6

78.1

189

400

R03DC03

ATC

montelukast; oral

1.4

77.9

3848

27276

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

77.8

1827

11099

PHM77

NOMESCO Finland

Endovenous obliteration of v.saphena parva

3.0

77.6

342

1091

N05AH04

ATC

quetiapine; oral

1.4

77.5

4060

29068

L04AD02

ATC

tacrolimus; systemic

3.3

77.5

291

843

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

2.6

77.4

442

1621

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

77.1

10173

83052

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

76.9

2062

12926

W19

ICD-10 Finland

Unspecified fall

1.5

76.8

2609

17223

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.9

76.7

1074

5646

B03XA02

ATC

darbepoetin alfa; parenteral

2.3

76.6

599

2541

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

76.3

2750

18371

R52.0

ICD-10 Finland

Acute pain

2.0

76.3

818

3928

GAE40

NOMESCO Finland

Operation on rib and soft tissues for thoracic outlet syndrome

10.1

75.9

R42

ICD-10 Finland

Dizziness and giddiness

1.3

75.8

6292

48343

L15

ICPC

Knee symptom/complaint

1.3

75.5

6349

48865

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.5

75.5

2962

20121

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

75.5

5078

37834

SPAT1216

SPAT

Assessment of functional ability

1.4

74.6

4170

30166

SPAT1301

SPAT

No procedures

1.3

74.6

7990

63501

A04

ICPC

Weakness/tiredness general

1.4

74.5

4065

29286

N05BA06

ATC

lorazepam; systemic, sublingual

1.7

74.3

1352

7682

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

73.9

2974

20296

PH1AT

NOMESCO Finland

Endovascular extension of superior vena cava and of arteries of upper extremity

20.0

73.7

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

73.6

1137

6161

N02BF02

ATC

pregabalin; oral

1.6

73.4

1690

10212

B01AF03

ATC

edoxaban; oral

2.1

73.3

684

3118

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

72.9

3357

23479

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.7

72.9

1331

7570

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.9

72.6

895

4512

R55

ICD-10 Finland

Syncope and collapse

1.4

72.6

3021

20742

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

72.4

2227

14387

I82.21

ICD-10 Finland

Emboli and thrombosis in the inferior vena cava

15.4

72.0

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

71.9

2504

16602

N05CD07

ATC

temazepam; oral

1.4

71.7

3184

22120

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.8

71.7

1200

6658

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

71.6

2365

15512

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.7

71.3

1334

7635

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

71.3

1739

10656

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

71.1

2727

18431

J94.8

ICD-10 Finland

Other specified pleural conditions

2.4

71.0

494

1991

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

70.9

5762

44076

E66.00

ICD-10 Finland

Metabolic syndrome

1.7

70.9

1362

7854

45199

ICD-8 Finland

Phlebitis and thrombophlebitis, Of other and unspecified sites

+∞

70.8

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.7

70.3

383

1372

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.0

70.2

798

3912

SPAT1262

SPAT

Handing over of treatment supplies

1.4

70.1

4422

32580

XG466

NOMESCO Finland

Sleep oxymetry

2.0

70.1

778

3783

FB1ST

NOMESCO Finland

Catheter-based therapy of pulmonary embolism

+∞

69.8

R06AE07

ATC

cetirizine; oral

1.3

69.8

10647

88115

R03AC03

ATC

terbutaline; inhalant

1.4

69.7

3251

22778

R03BA02

ATC

budesonide; inhalant

1.4

69.7

4300

31569

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

3.0

69.7

312

1005

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.1

69.2

706

3329

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.4

69.0

254

727

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

2.9

68.5

325

1081

K78

ICPC

Atrial fibrillation/flutter

1.5

68.5

2174

14133

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

68.2

4088

29862

WX320

NOMESCO Finland

Spinalanesthesy

1.3

68.2

6303

49033

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

68.0

6806

53493

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.0

68.0

716

3415

N18.8

ICD-10 Finland

Other chronic renal failure

2.1

67.8

676

3160

SPAT1211

SPAT

Application of soft bandage

1.5

67.7

2115

13704

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

2.2

67.6

597

2663

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

67.5

3105

21696

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.2

67.4

561

2443

WW200

NOMESCO Finland

Immunization

2.1

67.2

672

3145

D70.82

ICD-10 Finland

Drug-induced neutropenia

2.5

67.2

439

1719

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.3

66.9

259

765

A07AA02

ATC

nystatin; oral

1.6

66.9

1513

9100

JAH00

NOMESCO Finland

Laparotomy

2.0

66.7

729

3525

L16

ICPC

Ankle symptom/complaint

1.4

66.3

2780

19094

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.0

66.2

767

3786

FB1BC

NOMESCO Finland

Extensive angiography of arteria pulmonalis

13.9

66.0

N05AA02

ATC

levomepromazine; systemic

1.9

65.9

934

4926

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

2.8

65.9

327

1115

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.9

65.8

880

4557

N06AA09

ATC

amitriptyline; systemic

1.5

65.7

2355

15692

M25.5

ICD-10 Finland

Pain in joint

1.3

65.7

7859

63105

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.9

65.3

897

4686

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

2.9

65.2

307

1017

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

64.9

1753

10995

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

64.7

9470

77820

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.2

64.7

578

2590

N05AH03

ATC

olanzapine; systemic

1.7

64.7

1339

7872

J01CA08

ATC

pivmecillinam; oral

1.2

64.6

9673

79689

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.6

64.6

212

563

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

64.6

1088

6046

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

64.3

3097

21804

4549X

ICD-9 Finland

Varicose veins of lower extremities, Without mention of ulcer or inflammation

1.7

64.2

1272

7393

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

64.0

5216

39842

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

63.9

1600

9859

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

63.8

1910

12257

WX110

NOMESCO Finland

Infiltration anesthesia

1.2

63.7

18236

160859

M02AA07

ATC

piroxicam; topical

1.3

63.6

9264

76048

S06.0

ICD-10 Finland

Concussion

1.4

63.5

2588

17675

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

1.8

63.3

949

5093

R04.2

ICD-10 Finland

Haemoptysis

1.8

63.2

916

4866

A41.8

ICD-10 Finland

Other specified sepsis

2.2

63.2

531

2322

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

63.1

4942

37525

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.3

63.0

511

2201

PHD76

NOMESCO Finland

Resection of long saphenous vein

1.7

63.0

1127

6370

R03AK08

ATC

formoterol and beclometasone; inhalant

1.7

62.8

1083

6057

4512A

ICD-9 Finland

Phlebitis and thrombophlebitis, Of lower extremities, unspecified

+∞

62.6

XG410

NOMESCO Finland

Flow-volume spirometry

1.8

62.6

951

5126

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

62.3

2038

13325

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

62.2

1904

12275

J01CE08

ATC

benzathine benzylpenicillin; parenteral

2.7

62.2

346

1253

RS221, ,

NOMESCO Finland

2.6

62.2

360

1330

A12AA04

ATC

calcium carbonate; oral

2.4

62.1

427

1712

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.4

61.9

451

1856

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.8

61.9

310

1063

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

61.8

1196

6906

A02BC03

ATC

lansoprazole; oral

1.3

61.8

7314

58569

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.1

61.8

614

2867

ZX108

NOMESCO Finland

Inhalation

3.4

61.7

223

631

Z71.8

ICD-10 Finland

Other specified counselling

1.3

61.3

8196

66566

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

1.8

61.2

886

4705

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.0

61.2

659

3170

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.7

61.0

1097

6208

J45.8

ICD-10 Finland

Mixed asthma

1.9

60.9

750

3780

PH2ST

NOMESCO Finland

Endovascular thrombolysis of pelvic and lower leg veins with radiological guidance

107.7

60.8

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.2

60.8

527

2334

XW000

NOMESCO Finland

Bone marrow biopsy

1.8

60.6

1035

5774

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.5

60.1

2328

15739

JAL30

NOMESCO Finland

Omentectomy

2.8

60.0

305

1054

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.0

60.0

654

3159

WX872

NOMESCO Finland

Intensive care

1.7

59.9

1277

7562

A29

ICPC

General symptom/complaint other

1.4

59.9

3460

25085

J96.0

ICD-10 Finland

Acute respiratory failure

2.5

59.6

369

1409

RT360, ,

NOMESCO Finland

13.0

59.4

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

1.8

58.9

846

4481

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.1

58.9

542

2458

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

58.9

4996

38316

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.6

58.7

1554

9700

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

58.5

7088

56850

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.4

58.4

428

1766

M01AH02

ATC

rofecoxib; oral

1.4

58.4

3190

22915

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.8

58.0

919

5015

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

57.9

9457

78398

M05BA04

ATC

alendronic acid; oral

1.5

57.7

2263

15333

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

2.8

57.3

283

963

GD1CN

NOMESCO Finland

Lung circulation isotope imaging

15.4

57.2

A04AD12

ATC

aprepitant; systemic

2.2

57.1

492

2174

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

3.0

57.1

253

811

K29

ICPC

Cardiovascular sympt/complt other

1.7

56.9

1180

6937

R5140

NOMESCO Finland

Monitoring the use of the aid

1.4

56.8

2704

18973

R31

ICD-10 Finland

Unspecified haematuria

1.4

56.7

2729

19187

T82

ICPC

Obesity

1.8

56.7

900

4915

M01AX17

ATC

nimesulide; oral

1.3

56.6

6000

47319

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.0

56.5

260

851

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3.1

56.4

243

766

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

56.4

741

3816

S80.0

ICD-10 Finland

Contusion of knee

1.5

56.2

1712

11022

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

2.7

56.0

312

1131

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

56.0

6165

48841

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.5

55.9

1742

11266

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.8

55.8

829

4436

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

55.8

3391

24761

J45

ICD-10 Finland

Asthma

1.4

55.7

2399

16535

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.4

55.6

2367

16279

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.7

55.6

1053

6044

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

55.2

3190

23107

L04AD01

ATC

ciclosporin; systemic

2.3

55.2

432

1834

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

3.1

55.0

230

713

R03DA04

ATC

theophylline; systemic, rectal

1.6

54.9

1354

8310

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.8

54.9

879

4812

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

54.8

2078

13981

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

2.5

54.7

350

1358

R4120

NOMESCO Finland

Occupational therapy

1.6

54.7

1531

9673

S76

ICPC

Skin infection other

1.6

54.7

1323

8082

R52.2

ICD-10 Finland

Other chronic pain

1.8

54.3

886

4876

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

54.2

747

3905

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

54.2

2495

17398

J01CA04

ATC

amoxicillin; systemic

1.2

54.2

21393

193182

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.0

54.1

568

2707

N19

ICD-10 Finland

Unspecified kidney failure

1.7

54.0

1002

5719

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.6

53.9

325

1226

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.9

53.9

645

3220

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.5

53.9

1980

13242

K92.1

ICD-10 Finland

Melaena

1.6

53.8

1405

8737

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

1.8

53.7

835

4532

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.6

53.6

1347

8302

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.5

53.6

1513

9577

ZXA10

NOMESCO Finland

Bilateral

1.3

53.1

4578

35129

E86

ICD-10 Finland

Volume depletion

1.9

52.7

684

3507

A02BA02

ATC

ranitidine; systemic

1.3

52.6

4824

37316

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.8

52.5

746

3938

WVA20

NOMESCO Finland

Medicine administration

1.9

52.5

695

3588

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

4.6

52.4

125

262

N06AX21

ATC

duloxetine; oral

1.4

52.4

2708

19257

FBB20

NOMESCO Finland

Thrombendarterectomy of pulmonary artery in chronic obstruction

+∞

52.4

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.8

52.1

813

4417

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

52.1

10944

92806

RT172, ,

NOMESCO Finland

8.6

51.9

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

51.9

2618

18540

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

4.6

51.7

124

261

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

51.4

9349

78120

45198

ICD-8 Finland

Phlebitis and thrombophlebitis, Alia definita

+∞

51.3

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.0

51.3

545

2610

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

51.2

6454

51859

B01AE07

ATC

dabigatran etexilate; oral

1.7

51.2

968

5554

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

51.0

1281

7892

M79.1

ICD-10 Finland

Myalgia

1.3

50.9

3326

24532

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.4

50.8

2813

20224

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.7

50.8

956

5478

TPX15

NOMESCO Finland

Removal of vascular injection port

3.8

50.7

154

388

L01BC59

ATC

trifluridine, combinations; systemic

4.4

50.7

127

277

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.1

50.5

505

2365

A07AA09

ATC

vancomycin; oral

2.3

50.4

392

1660

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

2.4

50.4

349

1405

M48.0

ICD-10 Finland

Spinal stenosis

1.3

50.3

3220

23672

R03AC13

ATC

formoterol; inhalant

1.6

50.2

1191

7241

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

2.5

49.9

311

1192

N03AX09

ATC

lamotrigine; oral

1.7

49.8

905

5135

N02AA01

ATC

morphine; systemic, rectal

2.1

49.8

513

2429

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

49.7

4024

30591

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

49.5

6722

54428

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.4

49.2

2386

16774

FB1AC

NOMESCO Finland

Angiography of arteria pulmonalis

19.8

49.2

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

2.0

49.2

555

2715

M03BX02

ATC

tizanidine; oral

1.2

49.0

15285

134197

I81

ICD-10 Finland

Portal vein thrombosis

4.0

48.9

138

330

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.6

48.7

1087

6509

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.3

48.7

3167

23334

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

3.5

48.6

170

472

RD210, ,

NOMESCO Finland

2.3

48.5

370

1555

SPAT1260

SPAT

Consultation of another employee

1.3

48.4

4186

32096

JN6AD

NOMESCO Finland

CT of torso and neck

2.1

48.4

446

2025

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

1.9

48.1

590

2970

PH9AT

NOMESCO Finland

Expansion (PTA) of vein not elsewhere classified

75.9

48.1

PH7ZT

NOMESCO Finland

Intravenous removal of filter to inferior vena cava

86.8

48.0

J01CF05

ATC

flucloxacillin; systemic

1.5

47.8

1578

10321

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

47.7

2477

17615

GD1FN

NOMESCO Finland

Lung ventilation isotope imaging

12.2

47.3

M01AX05

ATC

glucosamine; oral

1.3

47.2

4882

38270

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

47.2

5215

41211

HA1AA

NOMESCO Finland

X-ray mammography

1.5

46.9

1806

12178

K28

ICPC

Limited function/disability (K)

1.9

46.9

598

3050

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.7

46.8

823

4627

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

2.1

46.8

446

2052

ZX112

NOMESCO Finland

Subcutaneous

2.0

46.7

515

2500

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

3.4

46.6

169

480

WX722

NOMESCO Finland

PEEP

1.6

46.6

1081

6536

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.0

46.3

521

2546

G44.2

ICD-10 Finland

Tension-type headache

1.3

46.3

2973

21851

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.3

46.3

177

520

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.6

46.3

266

981

RT274, ,

NOMESCO Finland

6.8

46.2

104

AA1BD

NOMESCO Finland

Extensive CT of head and brain

1.9

46.0

606

3124

NF3AA

NOMESCO Finland

Femur X-ray examination

1.9

45.9

567

2861

N03AX14

ATC

levetiracetam; systemic

1.8

45.8

672

3583

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

3.5

45.8

157

430

R07.1

ICD-10 Finland

Chest pain on breathing

2.2

45.7

381

1662

WX725

NOMESCO Finland

Noninvasive ventilation

1.5

45.4

1289

8165

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.1

45.4

436

2012

N18.0

ICD-10 Finland

End-stage renal disease

2.5

45.2

292

1139

M66.0

ICD-10 Finland

Rupture of popliteal cyst

2.3

45.2

358

1529

J01MA06

ATC

norfloxacin; oral

1.3

45.2

3059

22656

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

2.5

45.1

292

1140

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.0

44.9

514

2528

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

2.3

44.9

338

1413

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

1.9

44.6

533

2660

A99

ICPC

Disease/condition unspecnature/site

1.4

44.6

2511

18082

A12BA01

ATC

potassium chloride; oral

1.6

44.6

1129

6969

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

44.6

17142

152701

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

2.3

44.5

350

1490

K56.7

ICD-10 Finland

Ileus, unspecified

2.1

44.5

452

2130

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.7

44.5

800

4527

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

44.5

5905

47602

L01BA01

ATC

methotrexate; systemic

1.7

44.5

834

4774

M13.9

ICD-10 Finland

Arthritis, unspecified

1.5

44.4

1712

11544

SPAT1234

SPAT

Support of social functional capacity

1.5

44.3

1289

8207

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.7

44.2

897

5242

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

2.2

44.2

374

1642

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

3.1

44.0

189

596

A03

ICPC

Fever

1.3

44.0

3529

26761

V03AE02

ATC

sevelamer; oral

3.4

43.9

156

438

N03AE01

ATC

clonazepam; systemic

1.5

43.8

1265

8041

V03AE01

ATC

polystyrene sulfonate; oral

2.3

43.8

348

1488

L04AX03

ATC

methotrexate; systemic

1.4

43.7

2155

15182

P01BA02

ATC

hydroxychloroquine; oral

1.4

43.7

1837

12587

M09AX01

ATC

hyaluronic acid; parenteral

1.6

43.7

1182

7407

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.5

43.7

1514

9999

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.5

43.6

1438

9403

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

1.8

43.5

638

3403

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.5

43.4

280

1092

S22.3

ICD-10 Finland

Fracture of rib

1.4

43.3

1734

11777

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.5

43.1

1329

8568

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.7

43.1

833

4807

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

2.6

43.0

248

916

L03AA14

ATC

lipegfilgrastim; parenteral

2.1

43.0

415

1919

M01AH01

ATC

celecoxib; oral

1.3

43.0

4316

33674

R96

ICPC

Asthma

1.4

42.9

2294

16376

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

1.9

42.9

513

2561

PHM99

NOMESCO Finland

Endovenous obliteration of other vein

2.0

42.7

473

2299

S29

ICPC

Skin symptom/complaint other

1.3

42.7

4999

39708

J01FA10

ATC

azithromycin; systemic

1.2

42.7

13382

116936

R03BA01

ATC

beclometasone; inhalant

1.3

42.6

3262

24567

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.5

42.6

1427

9360

R81

ICPC

Pneumonia

1.6

42.6

913

5413

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.3

42.1

2591

18912

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.0

42.0

481

2366

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

1.9

42.0

557

2878

N02BF01

ATC

gabapentin; oral

1.4

41.9

2419

17480

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

41.9

16633

148164

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

1.8

41.9

661

3604

C08CA01

ATC

amlodipine; oral

1.2

41.8

10365

88701

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

4.2

41.7

111

254

196

Kela drug reimbursment

Paricalcitol and cinacalcet

3.6

41.6

140

379

SPAT1240

SPAT

Therapeutic discussion

1.4

41.6

1874

12997

R10.0

ICD-10 Finland

Acute abdomen

1.7

41.6

740

4176

L04AA01

ATC

[U] ciclosporin

2.3

41.5

333

1431

J01DA09

ATC

[U] cefadroxil

1.2

41.4

6027

49014

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.8

41.3

647

3519

ZZA00

NOMESCO Finland

Split skin graft

1.8

41.3

669

3675

Z3229

NOMESCO Finland

Other healthcare associate professional

1.4

41.3

1970

13798

R33

ICD-10 Finland

Retention of urine

1.4

41.3

2062

14556

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.5

41.2

1146

7224

R03AC12

ATC

salmeterol; inhalant

1.6

41.0

1073

6672

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.3

40.9

2697

19880

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.5

40.9

1454

9650

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

40.9

1511

10104

R18

ICD-10 Finland

Ascites

2.0

40.9

482

2396

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.9

40.8

536

2761

L02BA03

ATC

fulvestrant; parenteral

3.0

40.7

179

572

A10AB05

ATC

insulin aspart; parenteral

1.4

40.7

1755

12076

I82.1

ICD-10 Finland

Thrombophlebitis migrans

14.1

40.7

R05

ICD-10 Finland

Cough

1.2

40.6

5076

40591

A01AB09

ATC

miconazole; local oral

1.4

40.5

1981

13931

N05AX12

ATC

aripiprazole; systemic

1.8

40.4

665

3671

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.5

40.4

1436

9531

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

2.7

40.2

217

776

ZX121

NOMESCO Finland

Central venous catheter

3.9

40.1

117

287

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.2

40.1

6640

54679

4518X

ICD-9 Finland

Phlebitis and thrombophlebitis, Of other sites

+∞

40.0

C56

ICD-10 Finland

Malignant neoplasm of ovary

3.1

40.0

168

523

I83

ICD-10 Finland

Varicose veins of lower extremities

1.8

40.0

577

3063

R06.2

ICD-10 Finland

Wheezing

1.6

39.9

966

5901

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.4

39.7

1653

11301

ZY010

NOMESCO Finland

Hospital outpatient

1.6

39.7

942

5725

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

1.9

39.7

488

2460

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.6

39.7

1025

6356

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.8

39.7

654

3612

SPAT1251

SPAT

Organisation of medication

1.7

39.6

818

4802

L01CA04

ATC

vinorelbine; systemic

2.6

39.5

234

877

M70.6

ICD-10 Finland

Trochanteric bursitis

1.3

39.4

3156

23898

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

39.4

3248

24695

X57

ICD-10 Finland

Unspecified privation

1.9

39.3

519

2679

RS220, ,

NOMESCO Finland

2.4

39.2

281

1150

Z49.0

ICD-10 Finland

Preparatory care for dialysis

2.5

39.2

251

976

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.2

39.2

4840

38636

WX730

NOMESCO Finland

Conventional respirator

2.1

39.1

393

1846

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

1.7

38.8

693

3916

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.6

38.7

1048

6566

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.5

38.6

1319

8683

KBV00

NOMESCO Finland

Insertion of stent into ureter

2.9

38.6

183

611

E87.6

ICD-10 Finland

Hypokalaemia

1.6

38.5

835

4963

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

2.1

38.4

390

1839

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.8

38.3

593

3215

P19

ICPC

Drug abuse

3.0

38.3

167

532

L02BG06

ATC

exemestane; oral

2.0

38.1

405

1941

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

2.3

38.1

282

1171

S10

ICPC

Boil/carbuncle

1.5

38.1

1302

8574

K59.09

ICD-10 Finland

Constipation, unspecified

1.4

37.9

1689

11687

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

1.8

37.7

629

3485

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

3.2

37.7

152

462

N07BC02

ATC

methadone; systemic

4.0

37.7

109

266

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.5

37.6

1201

7797

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

37.6

10094

86740

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.3

37.6

2706

20189

M01AE02

ATC

naproxen; oral, rectal

1.2

37.6

13601

119756

SPAT1231

SPAT

Assessment of adjustments needed in living environment

1.9

37.5

457

2297

S01

ICPC

Pain/tenderness of skin

1.5

37.5

1076

6831

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

37.3

2123

15296

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.4

37.0

1649

11409

H05BX01

ATC

cinacalcet; oral

2.9

36.9

174

579

SPAT1125

SPAT

Stoma care and guidance

2.0

36.8

422

2078

FXA20

NOMESCO Finland

Total cardiopulmonary bypass in deep hypothermia and circulatory arrest at concurrent surgical procedure

7.3

36.7

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.3

36.6

2578

19171

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.5

36.6

1127

7263

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.4

36.5

1868

13229

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.7

36.5

728

4236

Z50.1

ICD-10 Finland

Other physical therapy

1.5

36.5

1205

7879

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.3

36.4

2284

16699

G04BD04

ATC

oxybutynin; oral, transdermal

1.5

36.4

1244

8189

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

1.8

36.4

545

2927

K95

ICPC

Varicose veins of leg

2.0

36.4

390

1876

N03AG01

ATC

valproic acid; systemic, rectal

1.5

36.3

1232

8099

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.5

36.3

1053

6701

Z02.7

ICD-10 Finland

Issue of medical certificate

1.4

36.2

1709

11940

WX306

NOMESCO Finland

Lumbar epidural anesthesy

1.5

36.1

1107

7126

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

4.1

36.1

228

JAH01

NOMESCO Finland

Laparoscopy

1.6

36.0

938

5828

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.4

35.9

1877

13341

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

35.9

2559

19062

N02AC04

ATC

dextropropoxyphene; oral

1.6

35.8

893

5493

L01AX03

ATC

temozolomide; systemic

2.8

35.8

177

605

J01FA09

ATC

clarithromycin; systemic

1.2

35.8

6989

58354

N06AB10

ATC

escitalopram; oral

1.2

35.7

4176

33102

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.6

35.6

961

6017

SPAT1172

SPAT

Guidance concerning hydration

1.8

35.6

596

3306

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.6

35.6

854

5206

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.6

35.5

901

5563

O22.8

ICD-10 Finland

Other venous complications in pregnancy

57.8

35.5

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

3.3

35.4

134

392

205

Kela drug reimbursment

Chronic hypertension

1.2

35.4

7084

59263

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

35.3

1941

13905

GD1FQ

NOMESCO Finland

Lung ventilation SPECT with low dose CT

11.1

35.3

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.0

35.2

362

1715

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

35.2

9501

81560

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.0

35.2

400

1965

-50

ICPC

Medication/prescr/renewal

1.6

35.2

905

5607

JMA10

NOMESCO Finland

Transabdominal total splenectomy

3.1

35.1

149

467

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.2

35.1

5135

41675

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

1.7

35.1

640

3637

R04.0

ICD-10 Finland

Epistaxis

1.4

35.1

1837

13060

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.4

35.0

2025

14627

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.4

34.9

1370

9262

U04

ICPC

Incontinence urine

1.4

34.9

1431

9755

M02AA10

ATC

ketoprofen; topical

1.3

34.8

3740

29354

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.7

34.7

708

4144

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

1.7

34.7

643

3671

C20

ICD-10 Finland

Malignant neoplasm of rectum

2.4

34.6

246

1004

A10AC01

ATC

insulin (human); parenteral

1.4

34.6

1677

11769

A79

ICPC

Malignancy NOS

2.0

34.6

403

1997

U07

ICPC

Urine symptom/complaint other

1.4

34.5

2042

14797

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.6

34.5

922

5762

PG1UT

NOMESCO Finland

Percutaneous aspiration throbectomy

3.3

34.5

129

375

Z72.2

ICD-10 Finland

Drug use

3.7

34.4

109

284

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.4

34.4

1365

9250

XF402

NOMESCO Finland

ECG with work load test

1.3

34.3

2439

18155

O87.1

ICD-10 Finland

Deep phlebothrombosis in the puerperium

173.5

34.2

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.2

34.2

302

1351

G03FA14

ATC

dydrogesterone and estrogen; systemic

0.6

34.1

510

8485

R60.1

ICD-10 Finland

Generalized oedema

2.7

34.1

189

686

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

2.4

34.0

226

895

E87.5

ICD-10 Finland

Hyperkalaemia

1.8

33.9

474

2492

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

2.3

33.9

260

1097

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

1.8

33.9

499

2666

M01AB05

ATC

diclofenac; systemic, rectal

1.2

33.9

16694

149990

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.4

33.8

1295

8714

J20

ICD-10 Finland

Acute bronchitis

1.3

33.8

2303

17036

ZY000

NOMESCO Finland

Hospital inpatient

2.4

33.8

239

974

N05AX08

ATC

risperidone; systemic

1.4

33.7

2005

14539

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.5

33.7

1084

7050

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.0

33.5

365

1766

C01DA14

ATC

isosorbide mononitrate; oral

1.2

33.5

4213

33635

321

Kela drug reimbursment

Paricalcitol and cinacalcet

2.8

33.5

166

568

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

2.2

33.5

270

1164

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3030467) Casts [#/volume] in Urine by Automated count

10795

74175

1.63

322.40

4.5

3.4

0.51

0.44

e6/l

1.71

8304

54728

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

422

492

8.36

316.21

1.1

7.00

2.61

u/ml

0.84

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

23130

191895

1.72

310.92

13.4

8.2

83.13

80.18

u/l

12.36

22350

181772

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

2469

2251

11.42

307.65

1.3

1.2

3.81

3.88

u/ml

0.07

1121

1094

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2583

2270

11.90

307.65

1.3

1.2

3.66

3.93

u/ml

0.20

927

905

(3023368) Bacteria identified in Blood by Culture

13014

73927

2.23

307.65

6.0

4.3

—

(3022096) Basophils/Leukocytes in Blood

16404

116586

1.79

307.65

8.8

6.5

0.64

0.68

19.12

15622

108841

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2447

6615

3.79

307.65

3.2

2.3

3.66

3.61

g/l

0.96

2353

6315

(3006315) Basophils [#/volume] in Blood

17517

127154

1.79

307.65

8.3

6.2

0.04

e9/l

2.85

15175

108402

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

6189

31455

2.13

307.65

8.6

7.3

5.07

5.09

kpa

0.57

5950

30224

(3013115) Eosinophils [#/volume] in Blood

17785

130790

1.77

307.65

8.7

6.4

0.18

0.19

e9/l

13.02

15624

113256

(3032080) INR in Blood by Coagulation assay

19582

121716

2.60

307.65

25.9

15.4

1.41

1.28

inr

160.74

16964

101745

(3019977) pH of Arterial blood

6191

31440

2.13

307.65

8.6

7.3

7.42

5.81

3509

17074

(3013826) Glucose [Moles/volume] in Serum or Plasma

19769

149909

1.80

307.65

7.6

5.0

6.77

6.78

mmol/l

0.37

19173

142593

(3020779) Urea [Moles/volume] in Serum or Plasma

4595

24069

1.99

307.65

9.2

6.9

10.54

10.49

mmol/l

0.16

4380

22901

(3036489) Thrombin time

4218

7541

6.11

307.65

2.3

1.9

21.32

21.24

0.20

3423

6901

(3034426) Prothrombin time (PT)

495

458

10.56

307.65

1.2

28.76

28.00

1.24

495

458

(3019069) Monocytes/Leukocytes in Blood

16476

116826

1.80

307.65

8.7

6.5

8.93

8.96

0.66

15690

109139

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

943

851

10.98

307.65

1.2

1.1

1.08

1.06

ratio

2.38

764

707

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

760

528

14.19

307.65

1.1

1.0

97.45

97.42

0.01

594

411

(4268621) Lupus anticoagulant assay

1763

1597

11.23

307.65

2.4

2.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

16742

118632

1.82

307.65

9.6

6.4

1.21

mmol/l

11.31

15837

109258

(3001604) Monocytes [#/volume] in Blood

17474

126715

1.79

307.65

8.3

6.2

0.61

0.60

e9/l

4.99

15139

108020

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5706

31676

1.91

307.65

5.1

4.3

253.22

243.53

u/l

4.41

5460

29941

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

2100

1431

15.12

307.65

1.2

1.1

96.86

96.56

0.13

1924

1365

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

2740

1981

14.56

307.65

1.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

8336

44809

2.10

307.65

2.4

1.9

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

13289

82533

1.99

307.65

3.7

3.2

1515.29

1552.43

ng/l

0.33

11862

71253

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

18222

132547

1.83

307.65

10.8

7.0

1.21

mmol/l

10.52

15928

113919

(3002582) Erythrocytes [#/volume] in Urine

12161

85803

1.62

307.65

4.7

3.5

85.09

89.79

e6/l

0.14

9618

65752

(3018010) Neutrophils/Leukocytes in Blood

16363

116791

1.77

307.65

8.4

6.3

59.19

57.79

40.62

15805

111193

(3019198) Lymphocytes [#/volume] in Blood

17744

129388

1.79

307.65

8.4

6.2

1.81

1.90

e9/l

7.43

15687

112940

(3018677) aPTT in Platelet poor plasma by Coagulation assay

7337

39818

2.03

307.65

3.0

2.0

30.39

29.66

13.48

7161

38699

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

577

718

7.87

307.65

1.2

1.1

18.64

7.81

u/ml

0.61

(3003396) Base excess in Arterial blood by calculation

6160

31230

2.13

307.65

8.5

7.3

1.16

0.92

mmol/l

5.17

5170

25785

(3016502) Oxygen saturation in Arterial blood

5523

28025

2.10

307.65

8.9

7.6

95.14

95.53

4.68

5330

27074

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

3307

5514

6.37

307.65

2.7

2.4

200.70

196.12

1.74

3088

5267

(3042936) Bacteria identified in Isolate by Culture

6536

36690

1.92

307.65

2.4

2.0

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

13369

51112

3.75

307.65

2.5

1.6

2.05

1.16

mg/l

86.80

11163

39760

(3003458) Phosphate [Moles/volume] in Serum or Plasma

6066

35058

1.84

307.65

8.0

5.6

1.04

mmol/l

0.32

5726

32407

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

6819

40257

1.82

307.65

3.2

2.6

20.86

22.22

13.17

6391

37167

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

3937

5731

7.47

307.65

2.4

2.1

97.30

89.96

59.76

3699

5557

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

6424

33349

2.09

307.65

2.2

1.8

—

(3006504) Eosinophils/Leukocytes in Blood

16426

116537

1.80

307.65

8.6

6.4

2.67

2.86

21.12

15642

108832

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

2746

1861

15.54

307.65

1.1

119.06

116.78

1.77

2438

1708

(3014111) Lactate [Moles/volume] in Serum or Plasma

4558

24314

1.95

307.65

9.0

7.2

1.33

1.36

mmol/l

0.71

4467

23790

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3528

17006

2.13

307.65

9.0

7.6

24.87

24.79

mmol/l

0.60

3502

16863

(3013650) Neutrophils [#/volume] in Blood by Automated count

19187

141690

1.85

307.65

14.6

9.3

4.31

4.20

e9/l

6.23

16967

122087

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

13144

94133

1.62

307.65

4.8

3.5

1.28

1.97

e6/l

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

8209

51081

1.75

307.65

5.0

4.1

274.24

472.80

ng/l

4.44

6823

41372

(3002030) Lymphocytes/Leukocytes in Blood

16673

119089

1.79

307.65

8.7

6.4

25.57

27.11

58.24

16001

112514

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

6052

31149

2.09

307.65

2.2

1.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

14121

99643

1.69

307.65

5.2

3.9

51.56

72.48

ng/l

0.88

11030

72494

(3002173) Hemoglobin [Mass/volume] in Arterial blood

5037

26039

2.04

307.65

9.6

8.1

121.00

120.65

g/l

0.55

4926

25460

(3027801) Oxygen [Partial pressure] in Arterial blood

6186

31439

2.13

307.65

8.6

7.3

11.59

12.35

kpa

25.93

5933

30211

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3903

19468

2.07

307.65

1.9

1.6

—

(3033658) Prothrombin time (PT) actual/Normal

10843

64293

1.98

307.65

5.7

4.1

86.27

88.26

11.44

10501

62950

(3000991) Gas panel - Venous blood

4388

23151

1.97

307.65

10.6

8.4

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

7947

43580

2.03

307.65

4.6

3.2

0.81

0.82

mmol/l

13.42

7571

40727

(4195642) Thrombophilia screening test

2696

1872

15.14

307.65

1.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

7221

43547

1.79

307.65

3.2

2.6

2.26

2.31

g/l

7.76

6733

39982

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

18704

134987

1.90

307.65

10.1

6.4

11.17

11.82

umol/l

9.34

18081

128463

(3022948) Iron [Moles/volume] in Serum or Plasma

7599

46575

1.77

307.65

3.2

2.6

11.67

12.74

umol/l

32.41

7120

43112

(3024561) Albumin [Mass/volume] in Serum or Plasma

16377

118508

1.73

307.65

7.3

4.9

33.93

35.41

g/l

190.10

15460

110590

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

905

759

11.81

307.65

1.2

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

3801

7639

5.34

307.65

3.6

2.7

0.37

0.34

iu/ml

6.53

2406

3997

(3018418) pH of Serum or Plasma

11798

79679

1.70

307.65

6.0

4.2

7.40

3.01

8843

57050

(36304419) Bacteria [Presence] in Urine

10211

69928

1.62

304.67

4.4

3.3

22.84

283.35

estimate

1.00

343

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3300

16171

2.08

301.62

10.3

9.0

24.46

24.25

mmol/l

3.18

3215

15748

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

11601

82258

1.59

297.02

3.4

2.7

66.98

62.89

u/l

0.20

10938

75975

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4840

27174

1.85

296.94

4.8

3.7

5.87

5.81

kpa

3.62

4710

26525

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2472

10893

2.29

294.73

2.2

1.9

2.49

2.20

ug/l

0.19

2208

9567

(3002032) Base excess in Venous blood by calculation

4731

26432

1.86

294.60

4.9

3.7

1.97

1.78

mmol/l

2.91

4176

23209

(3018095) Leukocytes [#/volume] in Urine

13171

96288

1.57

294.43

5.6

4.1

109.93

111.29

e6/l

0.05

9885

68524

(3012544) pH of Venous blood

4877

27577

1.84

291.98

4.8

3.8

7.38

0.50

2921

15928

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

10056

69726

1.59

278.52

2.8

2.4

3.15

2.86

mg/l

20.89

8860

59886

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3392

17289

2.00

276.81

4.7

3.6

5.16

5.15

kpa

0.37

3240

16407

(3009343) pH of Capillary blood

3305

16776

2.01

272.64

4.7

3.6

7.42

1.41

2836

13973

(3031040) Bacteria [#/volume] in Urine by Automated count

20286

164984

1.58

270.82

6.7

4.9

1865.74

1777.44

e6/l

0.07

348

2432

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

15272

116898

1.53

267.11

3.6

2.8

—

estimate

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4848

28098

1.79

264.93

5.1

4.1

36.34

23.30

ug/l

1.19

4022

23046

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2958

14616

2.05

262.37

4.4

3.4

2.12

1.83

mmol/l

3.76

2249

10749

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1634

6292

2.59

261.27

1.8

1.5

—

(3026782) Osmolality of Urine

7679

50662

1.62

257.81

3.9

3.0

519.66

531.33

mosm/kgh2o

5.25

6916

44357

(3000850) Epithelial cells [#/volume] in Urine

8696

59540

1.57

247.58

3.6

2.7

5.54

5.29

e6/l

1.09

8024

54175

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3277

17212

1.94

243.20

11.1

9.4

0.63

0.64

0.48

3252

17116

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3192

16665

1.94

241.03

7.6

6.7

24.77

24.51

mmol/l

3.34

3061

15975

(3014007) Fractional oxyhemoglobin in Arterial blood

3351

17800

1.91

240.25

11.0

9.2

93.51

93.91

3.16

3338

17744

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3339

17788

1.91

237.09

10.9

9.1

1.34

1.32

0.49

3313

17678

(3015377) Calcium [Moles/volume] in Serum or Plasma

12178

90383

1.50

235.86

5.1

3.4

2.35

2.36

mmol/l

11.63

11172

81575

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2976

15357

1.96

232.06

11.2

9.5

15.87

16.00

1.55

2870

14838

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1596

6478

2.45

227.63

1.9

1.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

4045

23205

1.78

225.58

3.2

2.6

65.01

66.35

g/l

22.33

3743

21094

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

8941

62796

1.53

221.59

3.1

2.4

—

(3021589) Normoblasts [#/volume] in Blood

14166

109396

1.47

219.17

17.8

11.6

0.00

e9/l

1.23

11550

88992

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2919

15339

1.92

214.82

4.8

3.8

24.30

24.20

mmol/l

0.96

2881

15122

(3024354) Oxygen [Partial pressure] in Venous blood

3937

22704

1.77

214.81

4.0

3.1

4.57

4.48

kpa

1.74

3819

22098

(3027945) Reticulocytes/Erythrocytes in Blood

5192

32368

1.66

212.73

3.2

2.4

1.90

1.77

13.85

4628

28623

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

6461

42592

1.59

210.50

4.0

3.2

2.77

2.68

e6/l

0.27

3290

20981

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11062

82053

1.47

206.25

4.3

3.2

34.09

34.65

u/l

0.37

10460

77135

(3037467) Urinalysis macro (dipstick) panel - Urine

20409

170230

1.49

206.04

6.5

4.7

2.48

50.45

0.50

276

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

11091

82345

1.47

205.62

2.6

2.2

212.43

210.23

u/l

0.10

10545

77586

(40767503) Oxygen content in Capillary blood by calculation

1350

5346

2.50

202.64

3.2

2.6

16.16

16.32

1.07

1326

5224

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1282

4972

2.55

201.05

7.2

5.2

3314.86

1202.14

iu/ml

0.36

235

717

(3027315) Oxygen [Partial pressure] in Blood

1330

5257

2.50

200.39

5.0

3.9

8.44

8.52

kpa

0.94

1303

5117

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6892

46699

1.55

196.92

3.8

3.1

1.30

1.19

e6/l

0.53

3737

25186

(3010421) pH of Blood

1774

8038

2.20

195.13

4.8

3.5

7.41

2.23

1747

7912

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4205

25390

1.69

192.78

2.5

2.2

0.20

0.21

g/l

4.82

3910

23556

(3013290) Carbon dioxide [Partial pressure] in Blood

1309

5236

2.47

192.13

5.0

3.9

5.00

4.99

kpa

0.16

1282

5097

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4041

24166

1.71

191.94

3.0

2.5

45.06

46.39

u/l

0.06

3456

20406

(3012501) Base excess in Blood by calculation

1308

5235

2.47

191.74

5.0

3.9

2.67

2.57

mmol/l

0.55

951

3532

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4750

29643

1.65

191.66

3.3

2.7

9.61

9.04

umol/l

0.73

4148

25969

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3714

21711

1.74

191.54

3.4

3.0

202.98

223.29

ng/l

1.75

3405

19940

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1148

4322

2.62

191.23

1.9

1.6

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

269

335

7.79

190.83

1.2

1.1

29.82

30.33

u/ml

0.01

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1948

9280

2.09

188.18

3.6

2.9

24.89

24.79

mmol/l

0.50

1913

9112

(1616796) Gas panel - Central venous blood

1387

5793

2.37

184.92

4.6

3.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3872

23138

1.70

183.77

2.7

2.3

367.87

382.05

nmol/l

3.67

3640

21391

(3028626) Oxygen [Partial pressure] in Capillary blood

1466

6316

2.30

181.88

3.8

2.9

8.06

8.01

kpa

0.46

1432

6157

(3026493) Urate [Moles/volume] in Serum or Plasma

9328

68229

1.46

180.50

3.6

2.8

358.88

346.31

umol/l

22.99

8202

59574

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1341

5605

2.36

178.38

1.6

1.4

—

(3017181) Myelocytes/Leukocytes in Blood

3816

22915

1.69

177.35

5.2

4.2

1.04

0.94

1.40

1613

6846

(3028271) Lactate [Moles/volume] in Capillary blood

1031

3853

2.63

174.14

2.2

1.8

1.66

1.74

mmol/l

1.97

1005

3745

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4203

26016

1.65

173.50

4.7

3.5

—

(3023520) Reticulocytes [#/volume] in Blood

4083

25099

1.66

173.16

3.3

2.5

72.78

68.44

e9/l

10.18

2877

18656

(4035726) Immunohistochemistry procedure

3710

22329

1.68

170.44

1.5

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

889

3124

2.79

169.27

1.7

1.5

—

(3002179) Metamyelocytes/Leukocytes in Blood

3605

21799

1.67

162.08

5.1

4.1

0.79

0.71

0.96

1510

6541

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1710

8216

2.06

160.76

1.4

1.3

—

(40758558) Short blood count panel - Blood

10039

75626

1.42

160.73

9.9

6.3

—

(3021901) Oxygen saturation in Capillary blood

1287

5544

2.29

159.38

3.6

2.9

89.77

89.61

0.38

1258

5385

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1572

7393

2.10

156.38

1.9

1.7

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

999

3876

2.53

156.07

3.1

2.5

9115.81

6874.25

u/ml

0.10

220

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1928

9773

1.96

155.83

2.5

2.2

431.96

591.48

ug/l

1.54

1839

9266

(3021440) Promyelocytes/Leukocytes in Blood

3596

21946

1.66

155.54

5.3

4.3

0.13

0.11

0.72

1405

5907

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

983

3826

2.52

152.53

1.6

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1141

4767

2.36

151.58

1.6

1.4

—

(3022806) Fractional oxyhemoglobin in Capillary blood

810

2884

2.75

150.31

2.0

1.8

89.36

89.48

0.21

798

2838

(44806071) Cardiolipin IgM antibody measurement

192

212

8.77

150.21

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

7430

53524

1.45

149.82

4.1

3.0

2.47

2.46

mmol/l

20.70

6648

47800

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1883

9606

1.95

149.18

4.0

3.4

5419.75

1626.72

u/ml

0.60

1609

8276

(3005719) IgG [Mass/volume] in Serum or Plasma

3142

18819

1.68

145.43

3.7

2.8

10.19

10.70

g/l

7.10

2962

17314

(3025159) Blasts/Leukocytes in Blood

3564

22094

1.63

144.04

5.4

4.4

0.23

0.34

0.67

1320

5630

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

835

3095

2.64

143.17

1.7

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1278

5749

2.19

142.23

1.6

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1115

4766

2.30

140.38

1.6

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

14172

114811

1.36

139.17

3.9

3.1

161.19

136.38

ug/l

10.77

13203

106220

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1821

9414

1.92

138.37

2.8

2.7

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2847

16843

1.69

137.61

4.2

3.2

126.11

128.51

g/l

6.56

2775

16360

(3019174) dRVVT (LA screen)

140

113

11.98

136.34

1.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2041

11016

1.84

135.52

1.8

1.5

14.34

14.93

iu/ml

0.06

248

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

909

3617

2.46

134.42

6.8

5.9

12.04

12.01

mg/l

0.07

844

3333

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3358

20850

1.62

134.17

5.8

3.7

1.22

1.23

mmol/l

1.82

3032

17817

(3021601) Nitrite [Presence] in Urine by Test strip

15989

132471

1.35

132.86

5.3

4.0

0.00

estimate

1.88

3899

27410

(3044009) aPTT.lupus sensitive (LA screen)

138

114

11.70

132.44

1.2

—

(3015736) pH of Urine

13262

107033

1.35

130.03

4.6

3.6

6.24

0.03

7326

58920

(3035350) Ketones [Presence] in Urine by Test strip

16142

134163

1.35

130.01

5.3

4.0

6.50

3.96

estimate

0.93

4037

28150

(3009261) Glucose [Presence] in Urine by Test strip

16242

135122

1.35

129.97

5.4

4.1

0.28

estimate

0.01

3820

26497

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2293

13065

1.75

126.54

2.0

1.7

1.67

1.54

g/l

7.52

2015

11110

(3018405) Lactate [Moles/volume] in Arterial blood

1665

8629

1.91

125.24

4.3

4.1

1.40

mmol/l

0.01

1627

8459

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1764

9318

1.87

125.12

1.4

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

4980

34256

1.48

124.17

1.9

1.8

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

21007

182623

1.36

120.50

5.9

4.5

15.60

12.81

mm/h

102.70

19801

170071

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1157

5338

2.13

120.48

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1157

5338

2.13

120.48

1.5

1.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1446

7256

1.97

119.60

1.9

1.6

0.24

g/l

3.38

1376

6899

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1472

7492

1.94

116.73

1.9

1.6

1.22

1.19

g/l

2.44

1408

7159

(3028026) IgM [Mass/volume] in Serum or Plasma

2482

14792

1.67

115.67

2.3

1.9

1.27

1.34

g/l

0.66

2309

13522

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2138

12251

1.73

115.23

6.0

4.7

1.61

1.60

0.10

2020

11659

(3004809) Band form neutrophils/Leukocytes in Blood

977

4289

2.23

115.20

3.7

3.5

1.57

1.56

0.02

872

3822

(3017143) Hepatitis C virus Ab [Presence] in Serum

3704

24347

1.53

114.13

1.8

1.6

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2420

14380

1.67

113.98

3.6

2.8

1.25

1.22

0.82

2412

14317

(3007930) Methemoglobin/Hemoglobin.total in Blood

1978

11149

1.76

112.91

6.3

5.0

0.86

0.87

0.69

1868

10576

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1303

6469

1.98

111.00

2.7

2.2

128.08

128.78

g/l

0.44

1044

4905

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

559

1921

2.84

110.85

1.7

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1684

9115

1.82

110.13

5.1

3.7

25.07

24.85

mmol/l

2.15

1557

8287

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2378

14265

1.66

107.72

3.6

2.8

0.63

0.62

0.21

2372

14219

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3202

20704

1.55

105.79

4.9

3.8

104.22

91.25

ng/l

9.60

2794

17659

(3037522) Nuclear Ab [Titer] in Serum

4826

33907

1.44

105.79

1.5

1.4

565.32

515.04

titre

1.02

1052

7442

(3035715) Granulocytes [#/volume] in Blood

944

4231

2.19

105.68

3.6

3.2

4.24

4.21

e9/l

0.15

939

4223

(44806118) Parainfluenza type 4 nucleic acid detection

755

3093

2.38

104.58

1.7

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

755

3094

2.38

104.50

1.7

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

755

3094

2.38

104.50

1.7

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

755

3094

2.38

104.50

1.7

1.5

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1988

11544

1.70

101.65

2.7

2.3

4.22

4.20

g/l

0.46

1833

10429

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1984

11521

1.70

101.43

2.7

2.3

3.80

3.72

g/l

1.26

1830

10402

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1989

11562

1.70

101.29

2.7

2.3

7.50

7.41

g/l

1.35

1832

10435

(3034860) Kappa light chains.free [Mass/volume] in Serum

1737

9752

1.76

100.18

4.2

3.2

57.76

72.37

mg/l

0.85

1447

8310

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1396

7340

1.87

99.97

1.8

1.4

15.09

14.41

iu/ml

0.07

148

(3020891) Body temperature

2131

12670

1.67

99.61

5.2

4.5

36.93

36.90

°c

3.91

2108

12549

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1733

9739

1.76

99.60

4.2

3.2

46.81

43.67

mg/l

0.18

1440

8300

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1125

5517

2.00

99.10

1.8

1.6

—

(3047181) Lactate [Moles/volume] in Blood

1462

7830

1.84

98.72

7.1

5.5

1.29

1.32

mmol/l

0.77

1296

6959

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

535

1910

2.73

98.69

1.7

1.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1579

8665

1.80

98.41

4.0

3.1

6.17

5.52

ratio

0.10

881

5082

(3019309) Folate [Moles/volume] in Red Blood Cells

6382

47620

1.37

97.39

1.9

1.8

1162.16

1158.24

nmol/l

0.12

4957

35815

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1522

8295

1.81

97.03

2.6

2.3

0.02

0.03

g/l

0.75

1365

7436

(3027273) Bicarbonate [Moles/volume] in Venous blood

2082

12409

1.66

96.29

4.7

3.4

25.34

25.23

mmol/l

0.71

2013

12033

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3431

22970

1.49

95.56

2.5

2.4

6.81

7.20

ug/l

0.39

2933

19950

(3021960) Folate [Moles/volume] in Serum or Plasma

9714

77279

1.31

95.46

1.9

1.7

19.29

20.27

nmol/l

8.91

8507

65265

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4326

30319

1.44

95.03

1.8

1.6

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1739

9921

1.73

94.63

2.9

2.5

1.06

0.88

g/l

0.83

1495

8444

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1133

5668

1.96

94.21

4.1

3.2

2032.52

825.93

u/ml

1.55

1018

5134

(3000494) Fungus identified in Specimen by Culture

4326

30367

1.43

94.12

1.7

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1739

9939

1.73

94.00

2.6

2.3

10.05

10.19

g/l

0.65

1562

8715

(3003434) Protein [Mass/volume] in Pleural fluid

865

3934

2.15

93.26

1.4

1.5

68.59

32.09

g/l

0.54

793

3556

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1863

10894

1.69

92.54

2.7

2.3

3.01

2.90

g/l

5.45

1709

9765

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2248

13805

1.61

92.11

5.0

4.0

47.67

47.10

0.52

2215

13628

(40761536) Microorganisms panel - Urine sediment

2972

19467

1.52

91.69

5.7

4.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1448

7966

1.79

89.32

2.6

2.4

0.00

g/l

2.34

1269

6965

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

459

1595

2.80

89.17

1.4

13.28

13.26

umol/l

0.02

436

1496

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1363

7377

1.82

88.77

3.8

2.9

1.83

1.60

mg/l

12.76

1248

6663

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

423

1423

2.89

87.28

1.7

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

1338

7275

1.81

85.78

4.7

4.4

3.89

mmol/l

0.14

1324

7215

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

409

1364

2.91

85.74

1.7

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

443

1559

2.76

84.04

1.7

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1350

7465

1.78

81.71

2.6

2.4

0.00

g/l

-0.00

1268

6948

(3023199) Leukocytes [#/volume] in Pleural fluid

761

3475

2.14

81.17

1.5

3350.25

2756.22

e6/l

0.25

529

2450

(3024928) Oxygen saturation in Venous blood

1236

6689

1.81

80.41

3.6

2.9

61.72

61.06

0.45

1185

6431

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

918

4509

1.99

80.37

1.6

1.4

—

(3045788) Cell count panel - Pleural fluid

646

2774

2.27

80.23

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

840

4022

2.04

78.97

1.6

1.4

157.16

152.57

au/ml

0.50

236

1158

(3026250) Tacrolimus [Mass/volume] in Blood

313

949

3.20

77.42

44.7

38.6

7.15

7.24

ug/l

0.32

290

838

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

903

4474

1.97

77.10

1.6

1.4

21.72

23.75

u/ml

0.16

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1734

10423

1.64

77.04

2.5

2.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

840

4061

2.02

76.89

1.4

1.2

279.80

276.07

u/ml

0.13

550

2539

(3039000) Anion gap in Blood by calculation

1036

5387

1.88

76.55

8.1

6.5

11.12

11.24

mmol/l

0.56

929

4878

(3017732) Neutrophils [#/volume] in Blood

4354

31599

1.38

76.53

4.0

3.1

4.59

4.63

e9/l

0.13

3771

26876

(3018572) Chloride [Moles/volume] in Blood

1036

5388

1.88

76.51

8.1

6.5

105.18

104.98

mmol/l

0.70

929

4880

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

882

4353

1.98

76.15

1.3

1.2

45.12

54.05

u/ml

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1967

12227

1.59

76.08

5.7

3.5

92.21

61.11

u/ml

2.08

1903

11804

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

25749

235569

1.38

75.97

31.3

16.9

27.12

25.51

mg/l

13.15

23964

195955

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2496

16369

1.51

75.79

1.5

1.4

—

(3042631) Mycobacterium sp identified in Specimen

755

3547

2.08

74.73

2.5

2.7

—

(3023183) Ammonium ion [Moles/volume] in Plasma

1077

5722

1.84

74.34

2.7

2.6

31.80

33.64

umol/l

1.90

976

5108

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

13530

114659

1.25

73.03

2.9

2.4

76.63

875.89

nmol/l

0.50

12299

102851

(3048929) Epstein Barr virus Ab [Presence] in Serum

1125

6092

1.81

72.96

1.3

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

615

2696

2.22

72.67

1.3

1.4

6.14

6.38

mmol/l

1.15

570

2518

(3052851) Hemolysis interference index of Serum or Plasma

1286

7294

1.73

71.06

4.0

3.3

1.97

2.07

index

0.25

707

3656

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1597

9604

1.63

70.68

2.2

1.8

—

(3023420) DNA double strand Ab [Units/volume] in Serum

1666

10154

1.61

69.81

2.0

1.7

9.74

7.24

iu/ml

1.44

385

2391

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

691

3230

2.08

69.32

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

7781

62102

1.28

69.09

4.8

3.9

0.09

0.27

1.46

666

(3028308) Erythrocytes [#/volume] in Pleural fluid

670

3103

2.10

68.88

1.4

1.5

55546.23

56661.28

e6/l

0.04

373

1766

(3025941) Bacteria identified in Stool by Culture

2005

12796

1.54

68.85

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1140

6333

1.76

67.75

1.7

1.6

—

(40768806) Pleura Pathology biopsy report

640

2953

2.11

66.45

1.5

—

(3023419) Bacteria identified in Sputum by Culture

710

3414

2.03

65.96

2.6

2.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

13777

117859

1.23

65.12

2.4

2.2

93.67

95.79

pmol/l

6.12

7957

62341

(3029937) Albumin [Presence] in Urine by Test strip

9129

74893

1.25

62.83

5.6

4.2

0.00

estimate

0.07

3583

24932

(3014051) Protein [Presence] in Urine by Test strip

8589

70021

1.25

62.38

3.9

3.0

0.10

0.08

0.31

239

1894

(3037756) Immunofixation for Serum or Plasma

1064

5950

1.75

61.74

1.8

1.6

—

(3037121) Protein [Mass/volume] in Urine

1444

8757

1.62

61.61

4.2

3.1

814.03

522.63

mg/l

0.66

779

3800

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

566

2582

2.13

60.55

2.0

1.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

5943

46575

1.29

59.43

1.8

1.5

2.55

2.52

g/l

0.51

3797

27945

(40768797) Stomach Pathology biopsy report

4700

35712

1.32

59.33

1.3

—

(3011412) CD3 cells [#/volume] in Blood

489

2125

2.24

59.08

2.2

2.3

1305.90

1148.06

e6/l

0.37

441

1890

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

397

1578

2.44

58.88

2.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

282

948

2.88

58.41

33.9

29.5

110.97

112.60

ug/l

0.18

235

787

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

382

1499

2.47

58.26

1.2

85.24

82.26

0.45

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

339

1263

2.60

57.62

1.9

2.0

102.28

96.44

2.04

313

1194

(3017569) Oxygen content in Arterial blood

374

1464

2.48

57.35

2.4

2.1

15.74

15.80

0.13

374

1464

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

531

2422

2.13

56.84

2.0

1.7

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

575

2704

2.07

56.79

1.3

468.95

467.43

u/l

0.01

534

2569

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

17863

158194

1.22

55.80

4.2

3.3

60.50

50.66

u/l

23.28

16843

147548

(21494815) CD4 cells/Lymphocytes in Specimen

439

1876

2.27

55.24

2.0

2.2

38.31

38.57

0.12

430

1839

(3017354) Segmented neutrophils/Leukocytes in Blood

593

2851

2.02

55.14

3.9

3.5

60.70

57.61

2.97

517

2423

(3044889) 12 lead EKG panel

19247

171841

1.22

54.90

5.1

4.3

0.44

1968.80

1.18

388

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

484

2174

2.16

53.91

1.9

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

484

2174

2.16

53.91

1.9

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

484

2174

2.16

53.91

1.9

1.6

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

385

1579

2.36

53.31

2.0

1.9

15.10

16.00

0.84

374

1535

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1235

7486

1.61

52.69

1.4

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1247

7602

1.60

51.95

1.6

1.5

0.24

9.22

iu/ml

2.21

261

1506

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

11695

99862

1.21

51.66

5.4

4.1

0.67

0.60

estimate

0.08

3260

22334

(3020876) Protein [Mass/time] in 24 hour Urine

655

3338

1.91

51.46

2.8

2.3

1.12

1.17

g/24h

0.22

428

1909

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

431

1883

2.22

51.45

1.3

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

479

2184

2.13

51.36

2.5

2.4

30.51

26.45

iu/ml

0.28

267

(1175426) CD3 cells/Lymphocytes in Blood

395

1668

2.30

51.16

2.0

73.04

72.13

0.51

381

1592

(3042111) Morphology [Interpretation] in Bone marrow Narrative

807

4402

1.79

51.00

1.8

1.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

544

2610

2.02

50.90

4.4

3.6

—

(3013512) EKG study

10653

90304

1.21

50.35

4.6

3.8

0.59

0.74

0.63

238

(3041096) Erythrocytes [Presence] in Urine by Automated

8431

69898

1.22

49.69

4.8

3.5

0.36

0.28

estimate

0.20

3195

21538

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

274

992

2.67

49.39

1.9

2.0

187.60

155.14

6.13

256

931

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

500

2361

2.06

48.89

3.1

2.7

—

(3035637) Corticotropin [Mass/volume] in Plasma

610

3090

1.92

48.82

1.6

1.5

28.35

30.08

ng/l

0.24

610

3079

(3044242) Glucose [Moles/volume] in Arterial blood

353

1452

2.36

48.60

2.2

1.9

7.81

8.25

mmol/l

1.55

353

1452

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

663

3460

1.86

48.42

2.0

1.9

23.77

26.11

ug/l

0.50

652

3384

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

106

207

4.94

48.37

1.2

0.76

0.13

u/ml

1.14

(3022145) Colonoscopy Study observation

3886

29503

1.31

48.36

1.4

—

(3000012) Reticulocyte production index

735

3963

1.81

48.30

2.8

2.1

0.97

0.89

2.64

550

2707

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1295

8101

1.56

48.27

1.5

1.4

255.06

266.84

ug/g

1.20

780

4745

(3042733) HLA Ab [Presence] in Serum

212

677

3.03

48.21

5.1

4.9

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

581

2913

1.94

47.95

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

763

4179

1.78

47.56

1.7

1.4

15.67

14.41

u/ml

0.12

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1010

5975

1.65

47.49

1.2

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

458

2122

2.09

47.13

1.3

12.11

14.08

u/l

1.28

415

1955

(3040151) Glucose [Moles/volume] in Capillary blood

600

3060

1.91

47.05

16.9

7.2

7.41

7.49

mmol/l

0.11

516

2521

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

163

451

3.49

46.83

1.5

1.2

164.68

22.09

mg/l

1.48

113

332

(3004451) EKG impression Narrative

360

1519

2.30

46.75

1.4

1.3

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

437

2014

2.10

45.62

1.5

1.4

12.14

13.37

u/l

2.96

417

1946

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

713

3880

1.79

45.44

4.9

3.6

44.97

37.77

u/ml

0.74

691

3757

(3010503) CD19 cells [#/volume] in Blood

332

1373

2.34

45.19

2.3

2.5

204.10

353.09

e6/l

0.69

323

1323

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1607

10683

1.47

44.88

2.0

1.9

38.35

39.46

u/l

1.24

1423

9353

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3001

22188

1.34

44.83

3.3

2.5

0.55

0.42

e6/l

1.19

2894

21265

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

415

1894

2.12

44.45

1.2

—

(3035880) pH of Pleural fluid

345

1463

2.28

44.31

1.3

7.40

7.41

0.09

246

1041

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

414

1892

2.12

44.19

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

396

1781

2.16

44.05

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

402

1822

2.14

43.84

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

529

2650

1.94

43.80

4.0

3.7

—

(3045142) Bone marrow Pathology biopsy report

567

2912

1.89

43.55

1.4

1.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

404

1843

2.13

43.34

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

2119

14923

1.39

43.07

1.5

1.3

199.01

248.83

u/ml

1.70

1973

13868

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

2704

19832

1.34

42.53

1.5

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

210

718

2.83

42.32

1.8

2.0

213.07

177.21

3.51

201

680

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

460

2230

2.00

41.89

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

415

1939

2.08

41.82

1.2

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

421

1980

2.06

41.68

1.2

1.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

654

3564

1.78

41.50

2.8

2.1

32.35

32.46

0.26

644

3545

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1104

6894

1.56

41.43

1.4

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

831

4868

1.66

40.60

1.4

1.2

274.93

257.42

titre

0.09

372

(3000475) Leukocytes [#/volume] in Synovial fluid

1083

6767

1.56

40.53

1.7

1.6

14949.51

14141.94

e6/l

0.20

742

4812

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

834

4896

1.66

40.41

1.4

1.2

227.50

111.36

titre

0.53

(40768446) Kidney Pathology biopsy report

235

875

2.60

40.16

1.9

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

311

1320

2.28

39.92

2.1

1.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

246

941

2.53

39.77

2.3

1.9

—

(3003129) Base excess in Capillary blood by calculation

586

3132

1.82

39.69

2.6

2.2

0.48

0.55

mmol/l

0.18

559

3017

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

310

1321

2.27

39.42

2.1

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

310

1321

2.27

39.42

2.1

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

310

1321

2.27

39.42

2.1

1.7

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

430

2093

1.99

38.75

2.3

1.7

4.04

4.02

mg/l

0.03

414

1999

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

242

931

2.51

38.68

2.4

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

242

931

2.51

38.68

2.4

1.9

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

191

656

2.81

38.22

1.1

87.82

87.41

0.05

311

(3024980) IgG subclass 4 [Mass/volume] in Serum

715

4096

1.70

38.03

1.6

0.75

0.80

g/l

0.47

553

3175

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

282

1173

2.33

37.97

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

228

863

2.55

37.71

1.9

1.7

11073.58

32880.32

u/ml

0.72

120

(3003694) ABO and Rh group [Type] in Blood

7919

66705

1.19

37.00

1.5

1.4

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

2775

20820

1.31

36.99

3.8

2.7

60.71

64.06

ml/min/173m2

3.72

1329

8864

(3037692) Legionella sp identified in Specimen by Organism specific culture

225

865

2.52

36.05

1.5

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1125

7275

1.51

35.93

1.6

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1042

6631

1.53

35.90

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

193

690

2.70

35.82

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

3836

30125

1.26

35.53

2.6

2.3

166.22

139.31

ug/g

4.14

3150

23712

(3016650) Hepatitis A virus Ab [Presence] in Serum

671

3857

1.69

35.27

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

1040

6641

1.53

35.26

1.2

—

(3002256) Pathology report gross observation

4315

34380

1.24

35.13

1.4

1.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1393

9473

1.44

34.39

1.3

0.82

0.92

u/ml

0.15

122

787

(3000492) Spirometry study

3005

23009

1.29

34.19

1.6

1.5

—

17.22

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1027

6588

1.52

34.08

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

476

2516

1.83

33.50

1.5

1.4

6.51

6.81

g/l

0.99

343

1808

(3024139) IgG subclass 3 [Mass/volume] in Serum

475

2515

1.83

33.25

1.5

1.4

0.39

0.42

g/l

0.76

342

1809

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

475

2516

1.83

33.21

4.8

4.0

80.78

54.56

u/ml

1.30

469

2479

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

6620

55333

1.19

32.99

1.8

1.7

21400358.50

30392616.63

pmol/l

0.73

5486

45413

(3028192) IgG subclass 2 [Mass/volume] in Serum

474

2517

1.83

32.87

1.5

1.4

2.78

2.94

g/l

1.10

344

1808

(4062490) Immunoglobulin typing, IgG

466

2466

1.83

32.69

1.5

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

841

5224

1.57

32.32

1.3

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

600

3428

1.70

32.29

2.6

2.7

107.94

877.89

u/ml

1.90

590

3389

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

360

1760

1.98

32.13

1.5

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

5459

44921

1.21

32.08

1.4

1.3

37.23

36.81

iu/ml

0.04

1679

13790

(3022493) Free Hemoglobin [Mass/volume] in Plasma

256

1101

2.25

31.96

3.3

4.1

616.77

1454.78

mg/l

0.59

200

754

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

384

1933

1.92

31.48

1.2

90.00

161.90

titre

0.99

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1037

6783

1.49

31.33

2.1

2.0

12.28

11.88

mg/l

0.72

964

6306

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

181

672

2.60

31.24

1.2

104.37

107.30

0.41

169

616

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

384

1938

1.92

31.24

1.2

197.60

172.93

titre

0.25

317

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

962

6202

1.51

31.19

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

146

485

2.91

31.16

2.5

2.0

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

531

2963

1.74

31.15

3.5

8.60

10.18

nmol/l

0.20

512

2875

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

502

2757

1.77

31.13

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

352

1734

1.97

30.76

1.5

1.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

254

1109

2.21

30.59

1.8

132.84

111.72

umol/l

0.40

129

568

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

319

1521

2.03

30.57

2.4

2.5

0.80

0.66

e9/l

0.40

298

1448

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

175

651

2.60

30.11

1.1

1.2

83.66

86.93

0.46

312

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

206

834

2.39

29.62

2.9

9.54

10.44

kpa

5.16

206

834

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

206

834

2.39

29.62

2.9

4.95

4.94

kpa

0.04

206

834

(3001964) Herpes simplex virus Ag [Presence] in Specimen

167

613

2.63

29.53

1.5

—

(3024932) HLA-DR beta [Type]

173

648

2.58

29.37

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

289

1350

2.07

29.31

2.7

37.90

38.64

0.24

156

766

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1050

6997

1.46

28.87

1.3

8.14

6.69

u/ml

0.34

175

1028

(21494890) Protein electrophoresis panel - 24 hour Urine

504

2836

1.72

28.73

2.5

2.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2052

15273

1.31

28.71

3.3

3.5

4.34

4.43

pmol/l

3.62

1825

13663

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1049

7008

1.46

28.47

1.3

8.56

5.20

u/ml

0.41

113

666

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

360

1836

1.90

28.43

1.3

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

279

1302

2.07

28.39

3.5

3.9

—

(3024471) HLA-A [Type]

174

666

2.52

28.27

1.0

—

(3008037) Lactate [Moles/volume] in Venous blood

1017

6779

1.46

27.93

4.0

3.2

1.54

1.60

mmol/l

1.33

995

6627

(3013727) Leukocytes other/Leukocytes in Blood

186

739

2.43

27.91

3.8

3.6

56.67

53.02

1.54

180

713

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

965

6369

1.47

27.89

1.3

10.04

11.98

u/ml

0.11

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

247

1110

2.15

27.74

3.4

3.5

1.39

1.28

0.42

247

1110

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

5.36

27.63

1.1

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

138

477

2.79

27.45

1.3

1.2

110.86

108.03

0.32

128

459

(21491868) Cryoglobulin [Mass/volume] in Serum

204

851

2.32

27.45

1.3

1.2

0.50

0.55

g/l

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

304

1485

1.98

27.28

2.4

643.63

516.94

e6/l

0.48

242

1218

(3051651) Icteric interference index of Serum or Plasma

296

1435

2.00

27.15

4.8

3.7

0.77

0.91

index

1.97

288

1399

(40762365) Oxygen content in Arterial blood by calculation

119

382

3.01

27.06

2.8

14.91

14.83

ml/dl

0.10

110

354

(3019550) Sodium [Moles/volume] in Serum or Plasma

25910

242575

1.22

26.86

34.9

20.3

139.51

139.65

mmol/l

15.25

25648

237756

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

737

4639

1.54

26.75

1.3

45.55

33.74

u/l

1.13

647

4007

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1098

7494

1.43

26.56

1.3

38.70

41.68

u/ml

0.13

398

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1736

21652

0.76

26.53

2.0

3.51

3.47

ratio

0.60

1382

16955

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

586

3504

1.62

26.51

1.2

29.51

11.76

u/ml

0.69

141

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

268

1265

2.05

26.48

2.4

2.3

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

309

1539

1.94

26.24

2.5

231.69

238.79

e6/l

0.20

263

1336

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

908

6001

1.47

26.07

1.3

1.2

7.55

5.20

u/ml

0.29

397

(3034770) Mitochondria Ab [Titer] in Serum

1022

6918

1.44

25.87

1.2

974.76

993.13

titre

0.03

208

(3019225) pH of Specimen

3212

25594

1.23

25.48

6.2

4.2

7.36

0.18

2557

18105

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1206

15777

0.72

25.46

1.7

3.46

3.47

mmol/l

0.14

840

11020

(3045414) Leukocytes [Presence] in Urine

3187

25402

1.23

25.20

2.5

2.1

0.00

0.02

estimate

9.02

595

4942

(3035947) Staphylolysin Ab [Units/volume] in Serum

260

1237

2.03

25.17

1.1

5.00

4.04

iu/ml

0.30

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

644

3988

1.57

25.16

1.1

—

(21494755) Public health laboratory ask at order entry panel

1375

17596

0.74

25.13

1.3

1.4

—

(3038515) Glucose [Moles/volume] in Venous blood

862

5685

1.47

25.03

4.3

3.4

7.48

7.66

mmol/l

1.13

842

5559

(3014148) Varicella zoster virus Ab [Titer] in Serum

470

2700

1.69

24.90

1.2

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

422

2354

1.74

24.89

1.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

332

1726

1.86

24.78

1.5

1.3

1.92

1.38

u/ml

0.54

198

1014

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

257

1225

2.03

24.76

1.6

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

257

1225

2.03

24.76

1.6

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

5006

41720

1.19

24.75

1.4

1.3

14.26

12.11

u/ml

0.60

1831

15879

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

269

1307

1.99

24.57

1.2

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

25916

242992

1.20

24.37

35.2

20.5

4.00

3.98

mmol/l

19.47

25644

237825

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

20967

193372

1.15

24.33

36.7

20.8

14.19

13.71

307.65

20788

190801

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

774

5037

1.49

24.04

1.5

1.4

268.68

156.40

pmol/l

2.43

757

4908

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

305

3.10

23.57

6.7

5.4

61.67

40.91

ug/min

1.93

244

(3009466) Valproate [Moles/volume] in Serum or Plasma

560

3416

1.59

23.38

5.8

5.0

347.90

354.37

umol/l

0.44

485

2945

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

323

1697

1.84

23.35

2.6

1.8

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

293

1494

1.90

23.26

2.1

1.8

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

208

938

2.14

23.25

1.4

64.82

63.71

0.17

164

772

(4281824) Cell count and differential, peritoneal fluid

462

2694

1.66

23.16

1.2

1.1

—

(3035285) Chloride [Moles/volume] in Venous blood

522

3157

1.60

22.61

2.9

2.4

105.79

105.52

mmol/l

0.68

517

3133

(3041354) Potassium [Moles/volume] in Venous blood

522

3157

1.60

22.61

2.9

2.4

4.03

4.08

mmol/l

2.18

517

3134

(3000330) Specific gravity of Urine by Test strip

1769

13327

1.30

22.52

4.5

3.5

1.02

ratio

0.99

1604

12015

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

123

446

2.66

22.42

1.3

1.2

93.11

80.87

1.69

134

(1761868) Lipid panel - Serum or Plasma

8197

86822

0.87

22.38

3.5

3.3

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

524

3187

1.59

22.18

1.6

1.5

57.41

59.53

0.56

325

1998

(3021162) Amylase [Enzymatic activity/volume] in Specimen

117

416

2.71

22.16

2.6

2.7

1011.52

1550.28

u/l

0.36

108

367

(3028707) Methadone [Presence] in Urine by Screen method

442

2581

1.66

22.06

5.1

2.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

513

3117

1.59

21.81

2.9

2.4

1.20

mmol/l

0.09

508

3094

(3001893) Eosinophils/Leukocytes in Pleural fluid

181

799

2.19

21.40

1.3

1.4

2.47

2.59

0.07

153

670

(40757373) Influenza virus identified in Isolate

123

457

2.60

21.38

1.6

—

(40768441) Liver Pathology biopsy report

331

1802

1.78

21.33

1.3

1.4

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

478

2874

1.61

21.25

2.2

2.08

8.52

titre

1.88

(3051611) Lipemic interference index of Serum or Plasma

442

2608

1.64

21.20

4.6

3.4

13.63

13.06

index

0.51

288

1401

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

325

2.91

21.15

2.0

1.9

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

121

449

2.60

21.09

1.2

84.18

68.57

2.29

132

(3049717) Cytology report of Urine Cyto stain

1451

10739

1.32

21.07

2.6

2.8

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

199

919

2.09

20.98

2.7

0.60

0.61

mmol/l

1.03

199

919

(3007566) Smooth muscle Ab [Titer] in Serum

1001

7007

1.39

20.96

1.2

99.19

129.62

titre

1.26

653

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1277

9302

1.34

20.73

1.8

1.7

0.33

0.31

mg/l

0.48

595

4420

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

260

1326

1.90

20.69

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

260

1327

1.89

20.65

1.4

1.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

111

400

2.68

20.52

1.3

8408.33

224197.00

u/ml

0.49

(3025468) Yersinia sp identified in Specimen by Organism specific culture

515

3183

1.57

20.39

1.6

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

545

3419

1.54

20.20

1.6

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

435

2595

1.62

20.00

1.2

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

100

347

2.78

19.89

3.3

2.6

71.92

53.90

mg/l

0.22

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

122

469

2.51

19.81

1.2

1.1

18.93

34.17

iu/ml

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

514

3197

1.56

19.80

1.6

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

514

3201

1.56

19.70

1.6

1.4

—

(3003181) Sodium [Moles/volume] in Urine

781

5298

1.43

19.62

1.4

61.64

60.75

mmol/l

0.25

606

4240

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

417

2475

1.63

19.58

1.6

1.5

—

(3012565) Volume of 24 hour Urine

237

1197

1.91

19.46

2.5

2.1

1821.93

1960.10

1.36

217

1047

(3024522) Salmonella sp identified in Specimen by Organism specific culture

532

3350

1.54

19.40

1.6

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1373

10203

1.31

19.36

1.3

1.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

104

374

2.68

19.34

12.4

11.3

5.31

5.41

mmol/l

0.11

104

374

(3023383) Lactate [Moles/volume] in Pleural fluid

183

847

2.09

19.23

1.3

3.54

3.43

mmol/l

0.18

162

784

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3171

25916

1.20

19.14

2.0

1.8

1.56

1.49

3.75

2697

22491

(3026051) Granulocytes/Leukocytes in Pleural fluid

143

601

2.30

19.09

1.4

26.90

21.03

1.38

111

502

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

529

3342

1.53

19.02

1.6

1.4

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

298

2.88

18.93

1.3

1.4

66.01

75.08

1.73

247

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

23940

236425

0.87

18.63

6.2

6.1

2.62

2.65

mmol/l

8.14

22131

219099

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

6221

53724

1.14

18.61

1.3

1.48

1.66

u/ml

0.66

1673

14125

(3024666) Lithium [Moles/volume] in Serum or Plasma

220

1101

1.93

18.59

14.8

13.8

0.64

0.63

mmol/l

0.15

208

1016

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

749

5093

1.43

18.59

2.4

2.2

4618.32

4836.86

u/l

0.07

286

1942

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

211

1043

1.95

18.49

16.1

13.4

886.64

2053.58

nmol/l

0.45

205

999

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

23337

230834

0.88

18.43

5.3

5.2

1.41

1.46

mmol/l

72.49

21524

213273

(40757494) Bilirubin.total [Moles/volume] in Blood

247

1293

1.85

18.19

2.3

2.1

17.03

25.84

umol/l

1.00

123

(3011288) Drugs identified in Urine by Screen method Nominal

626

4133

1.47

18.19

6.4

2.7

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

797

5510

1.40

18.01

1.5

1.4

12.54

11.17

u/l

1.68

652

4421

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

23514

232396

0.88

18.01

5.4

5.3

4.52

4.58

mmol/l

14.25

21826

216144

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

253

2.97

17.59

1.2

1.3

84.76

104.37

ug/l

0.57

161

(3014271) Vancomycin [Susceptibility]

258

1384

1.80

17.57

3.2

3.0

—

(21494434) Karyotype in Bone marrow

392

2357

1.61

17.52

1.2

—

(3006245) CD3-CD19+ cells/cells in Blood

171

800

2.06

17.51

2.1

2.0

9.10

9.85

0.31

155

741

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

217

1104

1.90

17.49

21.4

18.1

1494.91

2272.04

nmol/l

0.43

209

1055

(3042517) Benzodiazepines panel - Urine

166

3.43

16.81

3.2

2.5

—

(3009508) Creatinine [Moles/volume] in Urine

10188

91116

1.12

16.81

4.0

3.4

7.24

7.36

mmol/l

2.12

8556

76395

(3000919) Neutrophils/Leukocytes in Pleural fluid

158

730

2.09

16.75

1.4

20.74

20.32

0.07

143

658

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

435

2709

1.55

16.75

1.2

39.04

43.56

u/ml

0.12

143

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

775

5402

1.39

16.72

1.3

1.2

46.86

45.79

u/ml

0.06

495

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

20052

185968

1.12

16.55

4.9

4.5

14.99

14.88

pmol/l

7.96

18535

169898

(3013005) Retinol [Moles/volume] in Serum or Plasma

194

970

1.93

16.51

1.9

1.7

1.95

2.00

umol/l

0.34

179

881

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

167

793

2.03

16.46

2.0

1.9

29.90

29.66

0.06

157

752

(3036603) Volume of Urine

330

1932

1.65

16.45

1.6

1930.97

1930.87

0.00

324

1879

(3003329) Lymphocytes/Leukocytes in Synovial fluid

394

2410

1.58

16.42

1.7

1.5

31.09

28.99

0.49

236

1472

(3008295) Osmolality of Serum or Plasma

451

2845

1.53

16.40

1.4

279.48

276.76

mosm/kgh2o

1.47

351

2139

(43055442) Apixaban [Mass/volume] in Serum or Plasma

117

484

2.33

16.28

1.5

1.6

103.07

113.02

ug/l

0.49

405

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

281

1584

1.71

16.16

1.1

—

0.50

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

135

597

2.18

16.04

8.8

6.3

70.13

70.23

0.02

110

456

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

776

5456

1.38

15.91

1.6

1.4

1370.91

2588.61

e6/l

0.73

630

4320

(3006576) Bicarbonate [Moles/volume] in Blood

176

865

1.96

15.77

6.0

6.2

24.98

mmol/l

0.01

164

779

(40768795) Lymph node Pathology biopsy report

407

2537

1.55

15.65

1.3

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

476

3070

1.50

15.62

1.3

56.23

54.72

u/ml

0.04

188

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

766

5394

1.38

15.57

1.6

1.4

29.63

33.66

e6/l

0.18

587

4002

(3006922) Hepatitis E virus Ab [Presence] in Serum

319

1879

1.64

15.56

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

448

6391

0.67

15.51

1.1

0.65

0.63

ratio

0.31

922

(3020682) Albumin/Creatinine [Ratio] in Urine

9956

89223

1.11

15.45

4.7

4.2

12.00

8.47

mg/mmol

9.06

6359

55157

(3047189) Immunofixation for 24 hour Urine

229

1234

1.79

15.44

1.9

1.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

352

2139

1.59

15.13

2.1

2.0

9.09

1.92

u/field

0.56

197

1167

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

140

644

2.10

15.07

1.2

10.25

13.16

pmol/l

0.83

214

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

506

3330

1.47

15.04

2.0

1.8

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

394

2466

1.55

14.90

1.2

1.1

2.14

1.92

iu/ml

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

820

5881

1.35

14.85

1.2

3.51

3.70

0.27

732

(3003327) Ova and parasites identified in Stool by Light microscopy

1105

8270

1.30

14.82

1.7

—

(4198724) Urine methamphetamine measurement

146

687

2.05

14.81

4.2

2.0

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

375

2.44

14.72

1.4

1.2

455.95

137.40

u/l

0.41

262

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

9921

102094

0.90

14.57

2.0

1.9

1.44

1.34

mmol/l

17.75

8257

84873

(3000060) B lymphocytes [#/volume] in Blood

125

558

2.16

14.55

1.9

2.0

0.12

1.24

e9/l

1.34

271

(3019150) Specific gravity of Urine by Refractometry

6730

59184

1.12

14.50

5.5

4.3

1.02

1.12

kg/l

1.35

4812

39511

(3014891) Appearance of Pleural fluid

374

2.42

14.33

1.6

—

(4024509) Urine culture

1544

12098

1.24

14.14

2.3

1.9

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

102

424

2.32

14.11

1.3

1.2

1.08

1.32

mmol/l

0.21

263

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

587

4022

1.41

14.07

1.2

1.76

0.89

0.62

123

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

148

3.32

13.92

1.0

—

(3011985) Renin [Units/volume] in Plasma

545

3700

1.43

13.77

1.6

1.4

63.24

59.97

mu/l

0.14

491

3295

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

297

1776

1.62

13.70

3.8

3.6

136.55

169.80

nmol/l

0.63

291

1755

(3016750) Collection duration of Urine

246

1402

1.69

13.68

2.6

2.2

496.95

498.73

min

0.10

183

1030

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

479

3186

1.45

13.53

1.3

0.19

0.21

nmol/l

1.45

366

2535

(3020393) Adenovirus Ag [Presence] in Stool

208

2.87

13.28

1.2

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

153

3.21

13.22

1.1

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

24163

227280

1.12

13.20

28.7

16.8

76.67

78.00

ml/min/173m2

17.92

22968

211161

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

269

2.62

13.09

10.0

7.1

0.43

0.42

umol/l

0.02

234

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

176

923

1.84

13.06

1.4

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1832

14733

1.21

13.02

1.7

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

234

1336

1.69

12.96

1.9

2.71

2.55

u/field

0.13

166

931

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

194

1051

1.78

12.94

1.6

1.4

2587401.09

2162298.53

iu/ml

0.08

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

846

6231

1.32

12.83

1.4

1.3

578.29

553.70

mg/l

0.41

820

5948

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

4.06

12.79

9.4

9.7

102.57

107.39

g/l

1.24

(40761539) Cells [Type] in Urine sediment by Light microscopy

127

603

2.03

12.65

1.4

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

885

6572

1.31

12.64

5.5

4.3

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

186

1003

1.79

12.62

1.9

1.6

28.82

29.29

umol/l

0.23

180

933

(3017704) Immunofixation for Urine

253

1488

1.64

12.53

1.9

1.6

—

(3012516) Albumin [Mass/volume] in Urine

9699

87479

1.10

12.52

3.9

3.5

64.25

47.38

mg/l

7.55

6418

55506

(3018851) Theophylline [Moles/volume] in Serum or Plasma

221

2.75

12.45

2.0

1.7

52.02

46.30

umol/l

0.65

221

(3002619) Bacteria identified in Specimen by Culture

136

666

1.97

12.44

1.4

1.3

—

(40768443) Skin Pathology biopsy report

1512

11987

1.23

12.42

1.3

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

537

3714

1.40

12.27

1.4

1.3

0.17

0.25

nmol/l

1.42

264

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

415

2.23

12.18

1.6

1.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

499

3416

1.41

12.10

1.1

1.53

g/l

0.08

466

3107

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

430

2868

1.45

12.03

1.3

1.2

60.28

60.65

u/l

0.04

388

2508

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

525

3633

1.40

11.97

1.4

1.3

1.42

2.06

nmol/l

0.27

511

3492

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

107

492

2.10

11.66

1.3

1.2

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

257

2.55

11.64

2.7

3.1

1.46

1.13

mg/l

0.46

198

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

304

1902

1.54

11.64

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

149

770

1.87

11.64

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

355

2299

1.49

11.56

1.3

1.2

64.31

77.35

u/ml

0.28

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

117

3.38

11.54

5.2

5.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

109

509

2.07

11.41

1.2

—

(3034891) Synovial lining cells/cells in Synovial fluid

215

1245

1.67

11.36

1.5

3.98

4.04

0.01

251

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

354

2.29

11.35

1.4

1.3

43.13

41.38

mg/l

0.12

295

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

102

466

2.11

11.31

2.1

1.9

—

(3042951) Complement C1q Ab [Units/volume] in Serum

3.66

11.14

1.1

1.2

29.15

16.49

u/ml

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

401

2.19

11.07

1.3

1.5

10.75

12.03

0.20

191

(3020191) Ethanol [Moles/volume] in Serum or Plasma

306

1941

1.52

11.03

1.5

1.4

1.17

1.21

promille

0.22

246

1520

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

493

3426

1.39

11.00

1.4

1.3

394.95

328.32

pmol/l

0.56

419

2906

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

208

1207

1.66

10.93

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

745

5519

1.31

10.90

1.3

1.2

3.80

3.79

mmol/l

0.10

701

5222

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

376

2495

1.46

10.86

1.9

1.8

3051.43

2416.97

titre

0.18

(3004775) Volume in Urine collected for unspecified duration

308

1964

1.51

10.84

2.5

2.3

729.47

667.43

1.35

214

1311

(3026389) Candida sp identified in Specimen by Organism specific culture

518

3641

1.38

10.80

1.4

—

(3044927) Protein electrophoresis panel - Urine

411

2779

1.43

10.74

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

645

4701

1.33

10.62

4.0

2.0

—

(3038026) Centromere Ab [Units/volume] in Serum

304

1945

1.51

10.55

1.3

1.2

62.24

53.25

u/ml

0.17

126

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

454

2.08

10.52

2.1

2.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.91

10.45

3.8

4.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

135

703

1.85

10.36

1.1

1.2

—

(3007463) Buprenorphine [Presence] in Urine

5.19

10.29

7.0

8.7

—

(3024263) Appearance of Synovial fluid

218

1302

1.62

10.26

1.7

1.6

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

266

1667

1.54

10.18

1.3

1.2

95.47

95.04

u/l

0.03

238

1411

(3023487) Leukocytes [#/volume] in Peritoneal fluid

178

1012

1.70

10.14

1.8

2.0

1938.65

3010.69

e6/l

0.33

109

681

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

129

667

1.87

10.13

1.7

1.6

0.37

0.38

ug/l

0.07

103

459

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

368

2.17

9.99

1.3

1.2

144.44

336.67

ng/l

0.40

240

(3045424) Erythrocytes [Presence] in Urine

1594

12976

1.19

9.97

2.6

2.1

0.00

0.17

estimate

1.16

435

3815

(3023511) Choriogonadotropin [Units/volume] in Urine

350

2331

1.45

9.97

1.5

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

224

1357

1.59

9.95

1.1

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

166

2.79

9.83

1.5

1.4

15.23

16.62

pmol/l

0.23

146

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

177

2.72

9.80

2.0

2.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

259

1629

1.53

9.78

1.3

1.2

29.37

26.67

u/l

0.35

230

1351

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

298

2.30

9.76

3.9

2.9

39.56

40.53

umol/l

0.13

248

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

190

1111

1.65

9.75

1.5

1.2

55.92

62.42

0.37

126

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

129

676

1.84

9.73

2.1

1.9

53.38

37.92

u/l

0.35

118

620

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

330

2193

1.45

9.53

1.7

1.6

25.20

25.94

u/ml

0.09

429

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

248

2.41

9.50

1.1

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

128

675

1.83

9.48

2.9

3.0

2.01

1.83

ratio

0.36

117

619

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

192

1138

1.63

9.36

1.1

—

(3022621) pH of Urine by Test strip

2413

20406

1.15

9.34

3.2

2.7

6.01

6.06

1.66

1739

13871

(3010838) Calcium [Moles/time] in 24 hour Urine

629

4655

1.31

9.34

1.8

1.9

4.73

4.96

mmol/24h

0.93

553

4099

(3044007) Cell count panel - Peritoneal fluid

152

848

1.73

9.32

1.8

1.9

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

150

834

1.73

9.31

1.2

1.3

360.74

257.39

ug/l

0.25

452

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

231

1433

1.56

9.30

1.7

1.4

5.94

6.05

u/l

0.07

203

1221

(3019420) Tryptase [Mass/volume] in Serum or Plasma

211

1283

1.59

9.27

1.5

1.6

7.18

9.58

ug/l

1.94

196

1180

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

113

579

1.88

9.18

1.2

972.73

966.13

titre

0.02

124

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

209

1272

1.59

9.15

2.6

2.4

221.47

204.11

u/l

1.17

209

1258

(3041918) Cholesterol [Moles/volume] in Pleural fluid

108

547

1.90

9.09

1.3

1.2

1.90

1.51

mmol/l

2.85

332

(3009871) Measles virus Ab [Titer] in Serum

152

856

1.71

9.02

1.6

3312.59

3422.86

titre

0.09

140

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

132

2.92

8.95

1.2

1.1

1.24

1.11

u/field

0.38

(3004616) Nuclear Ab [Presence] in Serum

456

3245

1.36

8.89

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

377

2601

1.40

8.89

1.1

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

3.24

8.80

1.2

1.3

204.52

185.55

ug/g

0.22

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

853

6609

1.25

8.78

1.8

1.9

30.88

12.11

iu/l

0.61

321

2570

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

200

2.51

8.69

2.1

2.3

21.96

22.99

mg/l

0.15

186

(3052592) Norovirus Ag [Presence] in Stool

482

1.94

8.66

1.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

291

1926

1.46

8.64

1.3

2.27

2.19

mmol/l

0.40

274

1772

(3017315) Amylase [Enzymatic activity/volume] in Urine

215

1337

1.55

8.61

1.2

207.60

338.16

u/l

2.71

201

1235

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

4.10

8.58

1.2

1.0

1.39

1.22

u/field

0.24

(3021387) Prolactin [Units/volume] in Serum or Plasma

793

6120

1.25

8.46

1.9

1.8

314.32

294.13

mu/l

0.91

722

5582

(3032057) Clostridioides difficile [Presence] in Stool

106

547

1.87

8.46

2.3

1.7

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

108

562

1.85

8.40

7.1

7.2

6.11

5.53

kpa

1.05

108

562

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

101

3.15

8.40

1.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

439

3136

1.35

8.38

1.1

2.32

2.77

0.40

468

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

502

1.90

8.35

1.2

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

128

703

1.76

8.34

2.1

1.9

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

108

564

1.85

8.32

2.3

2.5

111.87

500.79

ug/l

1.01

108

564

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

134

748

1.73

8.26

1.2

113.25

111.26

0.37

120

665

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1819

15207

1.16

8.26

1.2

123.19

136.89

u/ml

0.80

595

5678

(3023323) Follitropin [Units/volume] in Serum or Plasma

1138

9145

1.21

8.25

1.4

30.21

30.53

iu/l

0.12

958

7892

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

309

2.15

8.19

1.4

1.7

—

(36660697) Celiac disease serology panel - Serum

2249

19103

1.14

8.18

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

243

1578

1.49

7.98

1.7

1.5

4.15

7.28

u/l

4.93

191

1260

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

127

706

1.73

7.96

1.2

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

120

2.89

7.95

1.9

1.4

24.06

22.86

mmol/l

0.87

(3016879) Cocaine [Presence] in Urine

737

5685

1.25

7.93

3.9

1.9

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

150

877

1.65

7.81

1.7

1.8

18424.92

11303.05

e6/l

0.43

457

(3002621) Streptococcal DNAse B [Units/volume] in Serum

205

2.40

7.81

1.1

1.0

521.29

238.77

u/ml

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

118

647

1.76

7.77

7.2

7.4

5.82

5.97

kpa

0.90

108

563

(3016244) Insulin [Units/volume] in Serum or Plasma

182

1118

1.57

7.74

3.0

3.2

30.15

25.50

mu/l

0.61

166

1051

(3000764) Benzodiazepines [Presence] in Urine

781

6085

1.24

7.70

3.8

1.9

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

469

1.89

7.67

1.4

1.3

68.64

401.31

titre

1.31

(3002331) Protein [Mass/volume] in Peritoneal fluid

116

636

1.76

7.65

1.2

1.4

29.99

37.88

g/l

0.38

482

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

139

802

1.67

7.63

1.3

1.2

0.33

0.30

g/l

3.60

116

646

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

126

711

1.71

7.52

1.1

—

(3028300) Cannabinoids [Presence] in Urine

785

6138

1.24

7.50

3.8

1.9

—

(3028433) Virus identified in Specimen by Culture

133

764

1.68

7.43

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

286

1944

1.42

7.43

1.8

1.9

8.05

9.40

umol/l

0.47

220

1411

(4015189) Microbial culture of sputum

122

685

1.72

7.42

2.7

2.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

126

717

1.69

7.30

1.3

1.4

15.62

13.36

g/l

1.75

545

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

22513

220705

0.93

7.29

4.6

4.4

1.37

1.28

mmol/l

54.06

20553

201813

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

137

2.67

7.29

1.6

1.5

0.85

0.82

mg/l

0.02

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

137

2.67

7.29

1.6

1.5

0.73

2.98

mg/l

3.39

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

137

2.67

7.29

1.6

1.5

1.90

1.86

mg/l

0.02

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

137

2.67

7.29

1.6

1.5

2.44

1.60

mg/l

0.33

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

137

2.67

7.29

1.6

1.5

1.78

2.49

mg/l

0.43

101

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

137

2.67

7.29

1.6

1.5

1.10

2.03

mg/l

1.41

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

137

2.67

7.29

1.6

1.5

0.44

1.28

mg/l

1.13

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

137

2.67

7.29

1.6

1.5

2.53

2.57

mg/l

0.01

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

137

2.67

7.29

1.6

1.5

5.15

4.33

mg/l

0.23

(3027008) Opiates [Presence] in Urine

780

6121

1.23

7.22

3.5

1.8

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

219

2.29

7.20

1.2

1.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1124

9154

1.19

7.09

1.7

1.6

20.11

20.68

u/ml

0.09

212

2000

(3020961) Endomysium IgA Ab [Titer] in Serum

1286

10601

1.18

7.03

1.1

197.32

208.37

titre

0.06

273

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

457

1.86

6.97

5.6

4.9

40.89

63.63

u/l

1.75

445

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

175

2.42

6.93

1.5

1.2

0.73

1.10

ml/s/173m2

1.40

112

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

211

2.28

6.91

1.3

1.4

14.60

16.18

pmol/l

0.17

175

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

351

1.98

6.89

1.4

7.96

213906.41

nmol/l

1.87

295

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

238

1590

1.44

6.84

1.3

1.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

142

2.58

6.82

1.6

1.5

1.41

1.98

mg/l

0.37

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

296

2059

1.39

6.78

1.2

101.76

108.09

pmol/l

1.29

296

2059

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

150

911

1.59

6.77

1.2

—

(3027944) Amphetamines [Presence] in Urine

764

6028

1.23

6.75

3.6

1.8

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

143

2.56

6.73

1.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

160

991

1.56

6.64

2.5

2.3

68.98

287.73

ug/l

1.12

149

949

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

234

1571

1.44

6.57

1.3

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

126

739

1.64

6.56

4.8

2.0

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

123

717

1.65

6.56

1.3

1.2

128.22

131.04

nmol/l

0.07

512

(40765096) Chromosome analysis panel by Banding

131

776

1.63

6.56

1.2

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.20

6.56

1.8

1.6

—

(44786800) Granulocytes/Leukocytes in Body fluid

318

2.00

6.55

1.2

1.4

23.47

25.22

0.15

248

(3015956) Eosinophils/Leukocytes in Blood by Manual count

346

1.95

6.47

2.6

1.98

2.55

0.64

339

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

314

1.99

6.41

2.2

2.9

109.44

70.61

pmol/l

0.54

273

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

219

1460

1.45

6.40

1.6

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

837

9638

0.83

6.35

1.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

681

5351

1.23

6.29

4.8

3.5

30.51

27.49

mg/l

1.34

505

3754

(3023410) Appearance of Cerebral spinal fluid

332

2383

1.34

6.28

1.7

1.5

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

202

2.24

6.26

1.3

1.6

—

(3016038) Potassium [Moles/volume] in Urine

270

1879

1.39

6.21

1.2

33.53

34.81

mmol/l

0.37

235

1616

(3036071) Salmonella sp Ab [Titer] in Serum

108

618

1.68

6.21

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

264

1833

1.39

6.16

1.4

1.3

75.29

68.68

titre

0.11

136

(40763590) HLA-DQ beta [Type]

3.05

6.11

1.0

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

126

754

1.61

6.09

1.5

1.2

34.00

22.21

0.72

115

(3047185) IgG [Mass/volume] in Urine

3.77

6.05

1.1

—

38.67

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

140

2.48

6.00

1.8

1.9

201.45

199.94

ng/l

0.04

127

(46236302) HLA-C [Type] by High resolution typing

3.01

5.99

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

193

1274

1.46

5.97

1.7

1.5

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

257

2.06

5.97

2.7

1.7

—

(3034988) Calcium [Moles/volume] in Capillary blood

432

1.81

5.96

1.8

1.7

1.18

mmol/l

0.02

409

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

269

1885

1.38

5.95

1.4

1.3

445.93

508.31

titre

0.11

142

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

561

1.70

5.92

1.3

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

198

1316

1.45

5.92

1.7

1.4

24.01

23.01

umol/l

0.18

190

1208

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

117

693

1.63

5.91

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

211

1423

1.43

5.84

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

285

2024

1.36

5.81

3.4

2.7

25.25

29.98

mg/l

1.68

233

1474

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

300

2149

1.35

5.79

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

115

683

1.62

5.76

2.2

1.9

7.94

8.92

mg/l

1.46

101

566

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

382

1.84

5.73

2.2

2.0

17.15

16.73

umol/l

0.12

382

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

448

3397

1.27

5.71

2.4

2.1

30.03

26.70

mg/l

0.63

175

1232

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

192

2.21

5.69

1.5

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

349

2563

1.31

5.68

1.6

1.4

182337.76

133594.13

e6/l

0.54

234

1712

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

224

1535

1.41

5.68

1.1

—

(3036180) Methadone [Presence] in Urine

6.13

5.66

2.3

2.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

123

746

1.59

5.66

2.8

2.5

154.83

146.22

nmol/l

0.41

108

658

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

168

2.29

5.65

1.2

1.1

1.66

1.67

iu/ml

0.01

(3026480) Teichoate Ab [Titer] in Serum

231

2.09

5.61

1.1

—

2.00

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

251

2.03

5.57

1.0

—

(3008898) HLA-B27 [Presence]

860

6999

1.19

5.56

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

479

3674

1.26

5.56

1.1

14.58

17.06

au/ml

0.34

839

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

134

2.44

5.53

1.3

1.1

0.35

0.63

iu/ml

1.15

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1954

16874

1.12

5.52

2.4

20.11

22.78

au/ml

0.69

168

1719

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.78

5.45

1.2

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

350

2592

1.30

5.39

1.3

1.55

1.45

nmol/l

0.84

318

2339

(40760410) HLA-B [Type] by High resolution

2.89

5.39

1.0

—

(40760409) HLA-A [Type] by High resolution

2.89

5.39

1.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

220

1522

1.39

5.31

1.2

1.1

87.89

84.31

u/l

0.31

200

1350

(3010370) Gastrin [Moles/volume] in Serum or Plasma

400

1.78

5.27

2.0

1.9

63.41

48.69

pmol/l

0.37

336

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.65

5.20

1.0

0.24

0.06

u/ml

0.44

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

218

1513

1.39

5.18

1.2

1.1

32.58

23.74

u/l

1.45

201

1336

(3013862) HLA-DP [Type]

2.82

5.17

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.82

5.17

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

701

5649

1.20

5.10

1.3

209.20

219.18

miu/ml

0.27

233

2410

(3036670) Protein [Mass/volume] in Synovial fluid

131

828

1.53

5.08

1.3

39.32

40.14

g/l

0.21

431

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

363

1.80

5.06

1.1

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

473

1.69

4.94

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

151

992

1.47

4.88

2.3

50.89

52.19

umol/l

0.18

129

847

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1394

11891

1.13

4.86

1.1

14.61

6.38

u/ml

0.26

136

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

299

1.87

4.84

1.1

22.65

19.10

u/l

0.54

195

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

518

6068

0.82

4.81

1.4

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1798

15603

1.12

4.70

1.9

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

197

2.05

4.60

4.7

2.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

250

1.93

4.59

2.0

0.68

1.02

mmol/l

0.98

154

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

340

1.79

4.56

1.6

—

(40758292) HTLV I+II Ab panel - Serum

419

1.70

4.54

1.5

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1963

17150

1.11

4.54

2.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

100

612

1.57

4.53

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

163

1104

1.42

4.52

1.9

1.6

3.85

6.55

nmol/l

0.61

139

920

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.60

4.47

1.0

0.12

0.03

u/ml

0.57

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

101

624

1.56

4.40

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

165

1129

1.41

4.34

1.1

1482.32

1562.15

miu/ml

0.45

165

1129

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

208

1483

1.35

4.27

1.1

4.69

7.14

nmol/l

0.55

280

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

237

1726

1.32

4.22

1.2

1.1

50.39

44.52

mg/l

0.48

208

1453

(40768793) Breast Pathology biopsy report

713

5859

1.18

4.22

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

617

5019

1.19

4.13

2.3

1.8

0.98

0.85

nmol/l

4.38

536

4218

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

267

1.84

4.11

1.0

1.1

0.01

0.44

u/ml

1.64

171

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1776

15533

1.11

4.05

1.3

41.61

54.48

au/ml

1.67

1020

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

154

1055

1.41

4.05

1.0

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

614

1.54

4.05

1.4

1.2

16.83

16.52

umol/l

0.27

530

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

6.66

4.04

2.7

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

111

715

1.50

4.03

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

106

2.36

4.01

1.7

1.5

471.13

490.95

nmol/l

0.07

106

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

208

1.94

4.01

1.1

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

5.04

4.00

1.2

0.91

1.67

0.47

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

319

1.75

3.99

1.5

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

341

1.72

3.97

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

341

1.72

3.97

1.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

226

1652

1.32

3.95

1.1

306.38

288.15

mg/l

0.28

204

1467

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

433

1.62

3.82

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

295

1.76

3.82

1.1

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.49

3.81

1.2

1.1

1.00

1.33

u/field

0.39

(3020911) Cortisol [Moles/time] in 24 hour Urine

124

827

1.45

3.81

1.7

1.4

234.33

207.34

nmol/24h

0.07

124

827

(3019768) Coxiella burnetii Ab [Presence] in Serum

140

2.13

3.79

1.5

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

743

6193

1.16

3.72

3.4

3.3

0.79

0.81

nmol/l

0.62

586

4981

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

341

1.69

3.71

1.2

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

475

1.58

3.68

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

160

1124

1.37

3.67

1.2

153.59

161.48

mmol/24h

0.64

160

1124

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

23198

220572

1.06

3.65

6.1

5.5

1.95

mu/l

0.17

21599

203055

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

202

1.91

3.64

1.9

1.8

1.66

1.69

mg/l

0.06

171

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

366

2876

1.23

3.58

1.4

29.39

31.71

u/l

0.67

315

2328

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

131

2.13

3.56

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

160

1132

1.36

3.53

1.2

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

2.33

3.49

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

638

1.48

3.44

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

440

5051

0.84

3.43

1.6

1127.49

1009.97

mu/l

0.33

353

4166

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

439

1.58

3.41

2.3

1.8

3.07

2.84

ug/l

0.10

267

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.35

3.41

2.4

1.5

93.56

136.55

ug/l

1.04

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

174

1.94

3.36

1.0

1.1

12.69

9.71

u/l

0.24

174

(3025577) Chromium [Mass/volume] in Blood

213

1590

1.29

3.27

2.2

2.37

2.32

ug/l

0.09

164

1335

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.70

3.27

1.1

—

(3028468) Fragments [Presence] in Blood by Light microscopy

6.74

3.27

3.1

1.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

111

2.17

3.23

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

295

2295

1.24

3.22

1.2

—

titre

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

102

680

1.45

3.21

1.8

2.4

1.01

1.03

ug/l

0.03

649

(3012898) Urea [Moles/volume] in Urine

254

1.74

3.20

1.2

1.4

150.99

164.34

mmol/l

0.34

217

(3026470) Cobalt [Mass/volume] in Blood

218

1642

1.28

3.14

2.2

3.67

3.79

ug/l

0.10

201

1523

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

356

2834

1.21

3.12

1.4

0.34

nmol/l

0.03

248

2080

(3007916) DNA double strand Ab [Titer] in Serum

278

1.70

3.11

1.6

1.3

293.33

91.44

titre

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

120

2.09

3.07

1.0

1.1

7.70

8.74

1.14

107

(3027035) Albumin [Mass/time] in 24 hour Urine

229

1.77

3.06

2.0

1.3

24.63

492.61

mg/24h

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

309

1.65

3.04

1.2

1.1

—

(3017400) Magnesium [Moles/volume] in Urine

2.91

3.03

1.5

1.0

2.60

2.50

mmol/l

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

108

2.14

3.02

1.0

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

121

2.07

3.01

1.1

20.02

21.51

0.80

108

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

121

2.07

3.01

1.1

37.65

36.52

0.90

110

(42529582) MDA5 Ab [Presence] in Serum by Line blot

106

724

1.41

2.95

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

106

724

1.41

2.95

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

106

724

1.41

2.95

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

106

724

1.41

2.95

1.1

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

2.53

2.89

2.2

1.6

133.44

199.58

nmol/l

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.27

2.88

1.1

1.0

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

104

2.13

2.87

1.0

1.1

28.88

31.09

u/ml

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

104

2.13

2.87

1.0

1.1

15.09

26.19

u/ml

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

170

1257

1.30

2.86

1.3

1.2

0.59

0.64

ratio

0.39

108

710

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

154

1124

1.32

2.85

2.4

2.0

38.82

40.00

g/l

1.61

154

1124

(40763480) Human metapneumovirus Ag [Presence] in Specimen

111

2.08

2.84

1.5

1.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

151

1.91

2.82

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

244

1890

1.24

2.82

1.1

302.53

288.92

mg/l

1.93

219

1715

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

118

2.04

2.81

1.0

—

(3006969) Lambda light chains [Mass/volume] in Urine

2.29

2.80

1.1

0.12

0.06

g/l

0.24

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

179

1.83

2.80

1.0

1.3

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.34

2.80

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

548

1.46

2.79

1.2

1.3

1.17

1.18

mmol/l

0.22

548

(44813793) Dust mix specific IgE antibody measurement

210

1601

1.26

2.79

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

194

1.79

2.76

1.1

1.0

0.03

0.04

u/ml

0.36

194

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

281

1.65

2.75

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.53

2.74

8.7

8.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

121

858

1.36

2.73

3.7

3.0

29.62

28.30

umol/l

0.78

649

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

245

1.69

2.73

1.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

113

2.05

2.72

14.4

11.8

739.11

286.22

e6/l

0.33

(3034614) HLA Ag [Interpretation]

3.04

2.71

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.15

2.70

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

329

1.58

2.65

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

26205

253912

0.94

2.60

45.0

25.9

130.54

134.34

g/l

286.95

26013

250907

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

2.31

2.57

6.2

5.7

499.41

412.23

umol/l

0.84

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.89

2.56

1.7

2.2

210.56

245.61

ug/l

0.30

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

162

1212

1.29

2.54

1.1

1.06

1.14

u/l

0.97

521

(3026361) Erythrocytes [#/volume] in Blood

26204

253877

0.95

2.53

44.6

25.7

4.36

4.45

e12/l

153.01

25717

247224

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

26204

253869

0.95

2.51

45.7

26.2

39.34

40.43

38.38

25989

250720

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

261

2067

1.22

2.50

1.8

1.7

372.90

349.36

mu/l

0.31

209

1634

(3024731) MCV [Entitic mean volume] in Red Blood Cells

26204

253862

0.95

2.49

44.5

25.7

91.71

91.38

23.86

25993

250824

(3033923) Metanephrine [Moles/time] in 24 hour Urine

514

1.44

2.49

1.2

1.1

0.66

0.80

umol/24h

0.48

241

(3010813) Leukocytes [#/volume] in Blood

26209

253902

0.95

2.47

44.7

25.8

7.06

6.78

e9/l

42.87

25732

247281

(3035941) MCH [Entitic mass]

26204

253850

0.95

2.46

44.5

25.7

30.27

30.38

16.90

25994

250808

(3002523) Influenza virus A Ag [Presence] in Specimen

420

3476

1.17

2.45

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

420

3478

1.16

2.44

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

125

1.93

2.43

4.0

3.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

146

1806

0.78

2.42

1.5

51.54

59.20

ug/l

2.12

146

1806

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

210

1632

1.24

2.42

1.9

2.1

17.35

16.78

nmol/l

0.47

200

1527

(3013166) Neutrophils/Leukocytes in Synovial fluid

106

753

1.36

2.41

1.6

1.4

59.14

57.02

0.24

641

(3035082) Kappa light chains [Mass/volume] in Urine

2.13

2.40

1.1

0.66

0.04

g/l

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

204

1583

1.24

2.39

1.1

9.85

8.25

iu/ml

0.40

387

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

4.21

2.39

1.0

1.1

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

285

1.59

2.38

1.1

1.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

23159

224968

0.96

2.37

7.4

6.8

40.30

39.68

mmol/mol

20.86

21626

209291

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

678

5815

1.13

2.36

1.1

5.14

7.72

eliau/ml

0.87

637

(4034850) Laboratory test

889

7742

1.11

2.36

15.1

10.8

—

(3007461) Platelets [#/volume] in Blood

26203

253797

0.95

2.35

44.7

25.8

249.43

248.18

e9/l

2.12

25795

248136

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

134

1.87

2.33

1.2

2083.58

4249.59

ng/l

0.91

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

148

1.82

2.32

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

310

1.55

2.32

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

364

1.51

2.32

1.1

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2215

20061

1.07

2.30

2.6

2.3

11.41

12.94

nmol/l

15.24

1953

17963

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

2.79

2.29

1.4

1.3

11.80

37.78

e6/l

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

163

1.77

2.29

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.23

2.27

1.8

1.1

35.61

50.41

umol/24h

0.31

(3050129) First trimester maternal screen panel - Serum or Plasma

295

3363

0.84

2.26

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

191

1482

1.24

2.26

1.5

1.35

1.24

nmol/l

0.61

141

1103

(3017509) Phencyclidine [Presence] in Urine

171

1.75

2.25

2.0

1.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

139

1040

1.29

2.23

1.1

600.77

467.34

ng/l

0.11

280

(3008116) Ketones [Moles/volume] in Urine by Test strip

583

1.39

2.23

1.4

1.5

0.19

0.29

mmol/l

1.20

115

(3010015) Selenium [Moles/volume] in Serum or Plasma

223

1.64

2.22

2.1

1.6

1.31

1.39

umol/l

0.78

151

(3044416) Complement C4 [Mass/volume] in Pleural fluid

137

1.83

2.19

1.3

0.09

0.07

g/l

0.30

103

(3038177) Helicobacter pylori Ab [Presence] in Serum

441

3707

1.15

2.14

1.3

1.2

—

(3035611) Eosinophils/Leukocytes in Synovial fluid

167

1.73

2.13

2.3

1.6

1.00

0.80

0.17

128

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

663

1.35

2.11

2.9

3.3

7.70

8.14

mg/l

0.26

539

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

112

821

1.31

2.11

1.3

1.4

14.90

15.49

pmol/l

0.62

677

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.58

2.09

3.4

4.7

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

2.14

2.08

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

339

2803

1.17

2.07

1.1

3.68

3.58

eliau/ml

0.03

111

1224

(3036005) Urine sediment comments by Light microscopy Narrative

3.55

2.07

1.0

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

527

1.39

2.05

2.0

1.6

189.91

125.12

au/ml

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

659

1.34

2.04

1.4

1.3

39.64

37.64

0.20

437

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

229

1.60

2.02

2.5

2.2

71.52

59.71

1.36

145

(3050794) Legionella sp Ab [Presence] in Serum

222

1.60

2.01

1.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

3.08

2.00

1.1

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.05

1.98

1.4

1.0

1.51

0.42

umol/24h

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.99

1.96

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

157

1.72

1.96

1.8

6.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

419

1.43

1.95

1.7

1.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

245

1983

1.19

1.95

1.3

9.84

9.16

mmol/l

1.29

229

1858

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

2.12

1.92

1.0

0.05

0.19

u/ml

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

658

1.33

1.91

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

151

1.72

1.91

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

527

1.37

1.90

2.3

2.4

6.72

7.56

mmol/l

2.15

336

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

350

1.46

1.89

1.6

1.7

1.14

1.07

nmol/l

—

(3020491) Glucose [Moles/volume] in Blood

219

1765

1.20

1.85

2.2

1.8

7.39

7.02

mmol/l

0.84

159

1239

(3009015) Lactate [Moles/volume] in Synovial fluid

297

1.49

1.84

1.2

1.3

7.64

6.44

mmol/l

0.30

142

(3011436) Histone Ab [Units/volume] in Serum

531

1.36

1.82

1.1

—

21.20

u/ml

—

(37021550) Renin [Units/volume] in Plasma --upright

474

1.38

1.82

1.3

1.2

110.39

59.45

mu/l

0.87

341

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

128

977

1.26

1.82

1.4

1.3

3.76

4.09

umol/l

0.50

120

846

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

139

1.73

1.81

1.1

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

176

1.64

1.80

1.1

1.2

31.33

21.47

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

432

3676

1.13

1.80

1.1

69.46

4089.52

iu/ml

0.66

683

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

452

3862

1.13

1.77

1.7

1.6

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

332

1.45

1.76

2.7

0.70

0.53

u/field

0.54

332

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.87

1.75

1.6

1.4

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

216

1.56

1.73

1.1

8.92

20.83

iu/ml

1.35

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

2.22

1.72

11.8

8.3

31.14

51.50

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

679

1.31

1.71

1.4

1.7

—

164.56

iu/ml

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

606

1.32

1.68

2.4

2.5

172.56

147.52

au/ml

0.16

(3024316) Viscosity of Plasma

121

1.75

1.67

2.4

1.9

1.67

1.71

mpas

0.09

(3027231) Wheat IgE Ab [Units/volume] in Serum

352

1.42

1.67

1.1

1.0

1.60

1.58

u/ml

0.01

293

(3020564) Creatinine [Moles/volume] in Serum or Plasma

26124

250120

1.04

1.64

38.3

22.4

83.99

79.44

umol/l

48.50

25897

246922

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

696

6118

1.10

1.64

2.7

2.3

141.57

108.90

ug/min

0.80

425

3545

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

108

1.78

1.62

1.5

1.6

0.75

0.13

u/l

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

217

2454

0.85

1.62

1.7

1.6

—

(3001729) Color of Synovial fluid

197

1.56

1.61

2.2

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

202

1644

1.18

1.58

1.2

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.21

1.56

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

455

1.35

1.56

6.0

6.7

10.90

10.46

0.62

455

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

325

1.42

1.56

1.2

1.3

54.85

51.39

0.17

149

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

139

1.66

1.54

1.0

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1272

11492

1.07

1.53

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

154

1229

1.21

1.51

2.2

122.58

110.07

ug/min

0.08

280

(3033086) Enterovirus Ab [Titer] in Serum

1.95

1.49

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

180

1462

1.19

1.46

1.2

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

127

1.67

1.45

1.2

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

2.75

1.44

1.7

2.6

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

173

1.56

1.42

1.7

1.6

—

(3020618) Glucose [Moles/volume] in Synovial fluid

1.75

1.40

1.2

1.0

5.24

5.30

mmol/l

0.03

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.75

1.40

1.4

1.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

260

1.44

1.40

1.1

1.0

0.68

0.91

u/ml

0.13

170

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

197

1.52

1.40

1.2

1.1

90.84

100.06

titre

0.35

197

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

136

1.63

1.39

1.1

1.0

3.20

3.13

u/l

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

1.85

1.38

5.7

5.8

1.40

1.17

mg/l

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

23635

228926

0.97

1.38

5.8

5.4

6.06

6.00

mmol/l

10.96

21736

209430

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

251

2107

1.15

1.37

4.5

5.6

106.20

107.57

u/ml

0.01

696

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

739

1.25

1.35

2.8

1.7

42.45

874.23

pmol/l

0.76

141

(3029396) Erythrocyte agglutination [Presence] in Blood

335

1.38

1.35

2.8

—

(3016330) Potassium [Moles/time] in 24 hour Urine

327

1.38

1.34

1.3

1.2

—

84.75

—

(44806420) Estimation of glomerular filtration rate

291

2472

1.13

1.33

2.7

2.6

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.51

1.30

1.2

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

185

1.51

1.30

1.0

1.1

—

0.39

—

(3018133) Calcium [Moles/volume] in Urine

412

1.33

1.30

1.9

1.5

2.61

2.74

mmol/l

0.19

374

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.85

1.29

1.2

1.0

0.03

0.04

u/ml

0.26

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

6948

68330

0.97

1.29

4.6

4.7

21.72

22.18

1.68

3489

34725

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

25823

247382

1.04

1.28

19.2

12.4

26.09

25.84

u/l

0.88

25339

239570

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

1.87

1.24

1.0

0.00

0.19

u/ml

—

(1617658) Protocol used for examination of sentinel lymph nodes

216

1809

1.15

1.24

1.0

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

462

4049

1.10

1.24

1.1

1.16

1.69

u/ml

1.36

254

2129

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.01

1.24

1.0

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

243

1.43

1.24

1.2

1.3

0.30

0.24

nmol/l

0.23

166

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

2.67

1.23

1.0

1.1

—

(4146454) Self-monitoring of blood glucose

283

3066

0.89

1.23

2.4

2.8

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

109

863

1.22

1.21

1.0

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

157

1.53

1.21

1.6

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

220

1.44

1.21

1.0

1.1

—

(40762814) Titanium [Mass/volume] in Blood

460

1.30

1.20

2.6

2.5

3.10

3.64

ug/l

0.80

182

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

213

1.45

1.19

1.0

1.1

—

(3027874) Urate [Moles/volume] in Urine

1.71

1.18

1.4

1.1

1.45

1.76

mmol/l

0.47

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

166

1.51

1.18

1.2

1.5

33.53

39.31

0.26

108

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

265

2872

0.89

1.17

1.5

59.39

60.99

ug/l

0.21

208

2356

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.53

1.16

3.0

2.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

246

2676

0.88

1.16

1.5

1.4

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

207

1.44

1.14

7.9

5.3

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

250

2714

0.89

1.14

1.5

1.19

1.22

ratio

0.29

146

1650

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

250

2714

0.89

1.14

1.5

0.99

0.95

ratio

0.28

144

1643

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

226

1913

1.14

1.5

—

(3001556) Androgen free Index in Serum or Plasma

106

1.63

1.14

2.6

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

364

1.32

1.12

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

364

1.32

1.12

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1854

17108

1.05

1.11

1.3

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

250

2707

0.89

1.10

1.5

1.19

1.16

ratio

0.21

144

1635

(3005033) Fetal Nuchal fold Thickness US

202

2212

0.88

1.08

1.5

1.26

0.01

141

1577

(3026657) Rickettsia conorii Ab [Titer] in Serum

2.17

1.07

1.0

1.1

—

371.20

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

212

2310

0.88

1.05

1.5

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

101

1.62

1.05

1.3

1.91

1.78

mg/l

0.11

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.29

1.04

1.0

0.03

0.09

u/ml

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

196

1.42

1.03

2.3

2.7

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.66

1.02

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

229

1.39

1.01

1.2

—

(3000285) Sodium [Moles/volume] in Blood

533

1.25

1.01

1.3

139.04

138.11

mmol/l

1.30

447

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1025

9348

1.06

1.00

2.0

—

(3028717) Thiamine [Mass/volume] in Blood

329

1.32

1.00

1.2

61.29

63.13

ug/l

0.30

329

(3003888) Timothy IgE Ab [Units/volume] in Serum

392

3453

1.09

1.00

1.1

3.59

3.84

u/ml

0.14

209

1722

(3047352) Trisomy 18 risk [Likelihood] in Fetus

207

2247

0.89

0.99

1.5

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

2.19

0.98

1.0

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

166

1396

1.15

0.97

1.1

25.48

19.73

u/ml

0.57

543

(3005011) Chlamydia sp Ab [Titer] in Serum

282

1.33

0.95

1.6

1.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

710

7270

0.94

1.5

1.4

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

115

943

1.17

0.94

1.2

12.16

10.96

mm/h

0.48

115

943

(3022475) Manganese [Moles/volume] in Blood

128

1.50

0.93

1.5

1.2

0.16

umol/l

0.19

128

(3007542) Rye IgE Ab [Units/volume] in Serum

113

1.53

0.91

1.0

2.21

0.14

u/ml

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

121

1.51

0.91

10.6

8.6

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.82

0.91

1.3

1.1

1.70

2.94

—

(3018291) Platelet Ab [Presence] in Serum

1.93

0.89

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

138

1524

0.87

0.88

1.4

1.3

234.42

164.60

pmol/l

0.52

138

1524

(3036312) Salmon IgE Ab [Units/volume] in Serum

107

1.53

0.86

1.1

1.0

0.08

0.18

u/ml

0.32

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

112

926

1.16

0.85

1.2

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

100

1127

0.85

1.1

1.0

2.37

0.92

u/ml

0.48

255

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.57

0.85

1.0

265.71

196.06

pmol/l

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.79

0.84

1.1

265.88

273.11

u/ml

—

(3020874) Milk IgE Ab [Units/volume] in Serum

104

1167

0.86

0.84

1.1

1.0

2.42

1.16

u/ml

0.26

363

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

172

1.40

0.84

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

375

3333

1.08

0.83

1.1

0.87

0.89

u/ml

0.03

167

1391

(3018001) Oat IgE Ab [Units/volume] in Serum

140

1.44

0.83

1.0

0.27

0.22

u/ml

0.11

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

1.75

0.83

1.0

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

195

1680

1.12

0.82

1.8

1.5

2.51

3.82

ug/l

2.20

144

1365

(3006270) Folate [Moles/volume] in Blood

241

2101

1.10

0.81

1.2

315.51

349.24

nmol/l

1.39

192

1717

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

567

1.21

0.81

1.1

1.2

348.34

286.10

pmol/l

0.61

407

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.67

0.79

1.0

0.04

1.83

u/ml

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.54

0.79

1.0

5.48

3.48

u/ml

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.78

0.0

1.2

—

0.47

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

241

1.32

0.78

1.3

1.1

1.83

1.72

umol/24h

0.29

241

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.72

0.78

1.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.80

0.78

1.7

1.1

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

19952

193175

0.98

0.77

37.8

22.1

329.76

331.92

g/l

198.79

19838

191988

(3032868) Hemoglobin electrophoresis panel in Blood

175

1.38

0.77

1.7

1.5

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.76

0.0

1.0

—

0.33

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

139

1181

1.13

0.75

5.8

504.67

3775.09

u/ml

0.48

190

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

267

2805

0.92

0.75

1.3

7.59

7.43

mmol/l

0.37

237

2407

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

1.53

0.73

1.1

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.82

0.73

1.1

1.0

0.01

0.10

u/ml

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.01

0.72

5.8

1.8

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

642

0.82

0.72

1.3

1.4

27.29

33.82

nmol/l

1.07

572

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

587

5338

1.06

0.71

2.1

1.9

193.19

199.56

pmol/l

0.72

557

5031

(3033099) Centromere Ab [Titer] in Serum

665

1.17

0.71

1.1

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

1.93

0.70

1.6

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

297

1.26

0.70

1.1

—

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

147

1.38

0.67

1.1

1.5

12.38

12.45

0.01

103

(3006462) Nitrate [Presence] in Urine

136

1167

1.12

0.66

4.1

3.3

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

1006

0.87

0.65

1.1

1.0

0.41

0.76

u/ml

0.46

236

(3010726) Horse dander IgE Ab [Units/volume] in Serum

351

3155

1.07

0.63

1.1

0.96

1.14

u/ml

0.35

181

1562

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

5157

50433

0.98

0.63

3.3

0.81

0.79

ug/l

0.43

3619

34035

(4211845) Urine protein measurement

148

1281

1.11

0.62

4.0

3.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

835

7700

1.05

0.62

1.9

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

158

1.34

0.61

1.0

0.01

0.02

u/ml

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.66

0.61

1.2

1.1

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.60

0.0

1.0

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

4.15

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

184

1.31

0.60

2.9

2.2

10.08

18.60

1.86

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

747

6879

1.05

0.60

2.0

1.8

40.34

43.15

nmol/l

3.20

734

6684

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

101

1.43

0.59

1.0

1.1

301.54

265.83

nmol/l

0.27

101

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3169

31123

0.98

0.59

5.0

5.2

31.88

32.81

5.16

2243

20458

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

180

1897

0.91

0.59

1.0

38.48

42.12

ng/l

0.68

126

1334

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

8961

85351

1.02

0.58

5.7

3.35

3.58

ug/l

0.29

8045

77006

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

770

0.86

0.58

1.7

1.6

0.93

1.59

u/ml

0.80

189

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

160

1.32

0.57

1.0

0.00

0.13

u/ml

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

180

1894

0.91

0.57

1.0

775.50

731.95

ng/l

0.71

123

1308

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

127

1.36

0.56

1.0

1.4

0.30

1.84

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

180

1891

0.92

0.56

1.0

305.97

349.13

ng/l

0.90

128

1350

(3013762) Body weight Measured

1.45

0.56

1.5

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.52

0.54

1.0

—

(40768800) Prostate Pathology biopsy report

600

5517

1.05

0.53

1.2

—

(40762887) Creatinine [Moles/volume] in Blood

214

1.26

0.53

1.6

1.4

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

105

1123

0.90

0.49

1.3

5.78

5.91

mmol/l

0.69

1057

(3006567) Chloride [Moles/time] in 24 hour Urine

1.53

0.48

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

218

1.24

0.47

1.1

1.2

6.19

6.08

mmol/l

0.30

218

(3022725) Serotonin [Moles/volume] in Serum

1.41

0.46

1.5

1.4

793.33

841.39

nmol/l

0.05

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

167

1.27

0.45

1.0

1.1

37.50

14.53

nmol/l

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

255

0.79

0.45

1.0

11.45

7.70

u/ml

0.36

255

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

125

1316

0.91

0.44

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

415

1.16

0.44

3.2

95.50

108.82

ng/l

0.12

148

(3020650) Glucose [Presence] in Urine

833

1.11

0.44

1.8

1.6

0.03

0.05

estimate

0.17

833

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

677

0.88

0.43

1.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

318

1.18

0.43

1.2

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.41

0.43

1.1

1.2

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.44

0.42

1.1

—

mmol/l

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.55

0.42

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

162

1451

1.08

0.39

6.2

7.2

26.06

105.22

ug/l

1.83

105

946

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

753

7476

0.97

0.37

2.0

1.7

5.20

4.49

mg/l

0.73

621

5604

(4212803) Bone marrow aspirate examination

243

1.19

0.37

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

260

2373

1.06

0.36

1.1

0.15

0.35

u/ml

1.35

100

770

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

320

0.84

0.36

1.1

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

173

1.22

0.36

1.1

1.0

2.13

0.48

u/ml

0.56

(3011841) English Walnut IgE Ab [Units/volume] in Serum

147

1.24

0.35

1.1

1.0

0.01

1.26

u/ml

0.72

112

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

113

1005

1.08

0.34

1.3

1.2

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

113

1.28

0.34

1.0

1.1

8.20

8.47

mmol/l

0.23

113

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

171

0.79

0.33

1.0

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

113

1007

1.08

0.33

1.1

9.51

5.95

u/ml

0.63

151

(3023430) Cat dander IgE Ab [Units/volume] in Serum

289

2655

1.05

0.33

1.1

3.59

3.29

u/ml

0.10

129

1146

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

594

1.10

0.31

1.4

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

283

0.85

0.30

1.4

1.8

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

142

1.22

0.29

1.1

1.0

0.18

0.51

u/ml

0.62

109

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

151

1.21

0.29

1.0

0.01

1.94

u/ml

—

(3019298) Eosinophils/Leukocytes in Peritoneal fluid

1.25

0.29

1.0

1.4

1.20

0.32

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

259

1.15

0.28

2.6

2.3

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.29

0.27

1.0

—

(3025130) Human papilloma virus identified in Specimen

328

3045

1.04

0.26

1.7

1.8

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

593

1.09

0.25

1.1

1.0

8.79

8.84

u/ml

0.01

367

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

119

1.21

0.24

1.2

1.4

1.00

1.13

u/field

—

(3000034) Microalbumin [Mass/volume] in Urine

226

2264

0.96

0.23

3.2

2.9

94.35

45.42

mg/l

1.37

167

1629

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.21

0.0

1.2

—

2.32

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.17

0.21

2.2

1.2

1.37

2.14

g/l

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

479

1.09

0.21

1.1

1.0

0.61

1.62

u/ml

1.10

247

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

221

1.13

0.21

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3168

30754

0.99

0.20

10.4

7.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

753

7118

1.02

0.19

1.2

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

727

0.94

0.18

1.7

1.9

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.20

0.18

1.0

1.2

32.03

34.13

mg/24h

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

300

2808

1.03

0.18

1.1

3.23

3.11

u/ml

0.05

150

1355

(40765089) Chromosome analysis panel - Blood by G-banded

389

0.92

0.18

1.1

1.0

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

198

0.87

0.17

1.7

2.9

4644.48

59.21

pmol/l

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

243

1.11

0.17

5.6

6.4

7.93

8.55

0.30

243

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

401

1.08

0.17

1.1

26.07

31.64

iu/ml

0.28

401

(40758358) Immune stain study

106

1.18

0.17

1.0

—

(3007700) Barley IgE Ab [Units/volume] in Serum

1.19

0.17

1.0

1.1

1.42

0.39

u/ml

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

387

0.92

0.16

1.1

1.2

—

(4133840) Spirometry

605

0.94

0.16

1.3

1.2

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.15

0.16

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

244

1.10

0.16

2.8

3.2

41.93

44.49

0.25

244

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.20

0.15

1.0

1.1

0.00

1.11

u/ml

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

136

1.13

0.13

1.8

1.4

348.69

334.04

umol/24h

0.09

136

(3045683) HLA typing for celiac disease panel - Blood or Tissue

123

1225

0.97

0.12

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

1.17

0.12

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

162

0.89

0.12

1.2

72.13

69.76

ug/l

0.03

162

(3027974) Hepatitis B virus e Ag [Presence] in Serum

129

1.12

0.10

2.0

1.5

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.12

0.10

1.2

1.6

1.44

2.10

mmol/24h

—

(3012403) Metanephrines [Moles/time] in 24 hour Urine

1.05

0.09

1.0

1.1

—

23.24

—

(4038314) Semen analysis, post vasectomy

1.07

0.08

1.1

1.2

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

169

1.08

0.08

1.0

0.01

0.12

u/ml

2.06

111

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.85

0.07

1.3

1.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.13

0.07

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

123

1.10

0.07

2.1

1.5

—

(3051101) Glucose [Moles/volume] in Cord blood

475

1.03

0.05

5.0

5.7

9.24

8.56

mmol/l

0.31

475

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

153

1.07

0.05

1.2

1.4

—

20588.50

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

677

1.02

0.05

1.8

1.7

10.73

9.26

ug/l

1.19

677

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2630

25254

1.00

0.04

1.6

—

6.31

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

134

0.93

0.03

1.3

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

232

1.04

0.02

2.3

0.70

0.67

ug/l

0.16

232

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

109

0.97

0.00

1.1

1.0

0.02

0.17

u/ml

1.40

109

(46235168) Fasting glucose [Moles/volume] in Blood

267

1.01

0.00

2.3

8.30

7.30

mmol/l

0.80

117

(3041806) Other cells [#/volume] in Blood by Manual count

331

0.99

0.00

1.7

1.6

0.48

0.51

e9/l

0.31

331

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

303

1.02

0.00

1.0

84.82

81.72

ug/l

0.14

223

(3003577) Lead [Moles/volume] in Blood

180

1.02

0.00

1.5

1.4

0.30

0.20

umol/l

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.00

0.00

1.0

1.1

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

-0.00

0.0

1.2

—

170.60

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3032642) Schistosoma sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(40760512) CD34 cells/cells in Bone marrow

0.00

-0.00

0.0

1.2

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

1.01

-0.00

1.0

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

3.7

—

(3006392) Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

-0.00

0.0

2.5

—

4.50

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3020132) Chylomicrons [Presence] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_VTE and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_VTE	2.165 [1.99, 2.36]	< 0.001
Birth year	0.993 [0.99, 1.0]	0.076

During the follow-up period (1.1.1998 — 31.12.2019), 32766 out of 80974 females with I9_VTE died.

Males

Parameter	HR [95% CI]	p-value
I9_VTE	2.234 [2.03, 2.46]	< 0.001
Birth year	0.984 [0.98, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 24507 out of 61597 males with I9_VTE died.

Mortality risk

Mortality risk for people of age

years, who have I9_VTE.

N-year risk	Females	Males
1	0.205%	0.471%
5	1.27%	2.114%
10	2.873%	5.435%
15	5.339%	10.021%
20	9.226%	17.1%

Relationships between endpoints

↥

Index endpoint: I9_VTE – Venous thromboembolism

GWS hits: 69

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Venous thromboembolism

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints